{"content":"<li class=\"n-box-item date-title\" data-end=\"1518238799\" data-start=\"1518152400\" data-txt=\"Monday, December 23, 2019\">Friday, February  9, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3330016\" data-ts=\"1518217500\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CDK\" target=\"_blank\">CDK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330016-cdkplus-9_4-on-chatter-carlyle-silver-lake-are-near-buyout-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CDK +9.4% on chatter Carlyle, Silver Lake are near buyout deal</a></h4><ul>    <li>Shares in software maker CDK Global (NYSEARCA:<a href='https://seekingalpha.com/symbol/CDK' title='CDK Global, Inc'>CDK</a>) are <font color='green'>up 9.4%</font> after hours with chatter on Bloomberg that Carlyle Group (NASDAQ:<a href='https://seekingalpha.com/symbol/CG' title='The Carlyle Group'>CG</a>) and Silver Lake are close to a buyout deal.</li>    <li>That deal would be for <a href=\"https://twitter.com/trading_mz/status/962093174427734017\" target=\"_blank\">at least $10B</a> and other P-E bidders reportedly aren't in active talks.</li>    <li>CDK, which specializes in automotive and retail solutions, had a market cap of about $9.17B at the close today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3330016\" data-linked=\"CDK +9.4% on chatter Carlyle, Silver Lake are near buyout deal\" data-tweet=\"$CDK $CDK $CG - CDK +9.4% on chatter Carlyle, Silver Lake are near buyout deal https://seekingalpha.com/news/3330016-cdkplus-9_4-on-chatter-carlyle-silver-lake-are-near-buyout-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3330016-cdkplus-9_4-on-chatter-carlyle-silver-lake-are-near-buyout-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:05 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330013\" data-ts=\"1518216610\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRUB\" target=\"_blank\">GRUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330013-analysts-boost-targets-on-grubhub-after-yum-infusion\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts boost targets on GrubHub after Yum infusion</a></h4><ul>   <li>GrubHub (NYSE:<a href='https://seekingalpha.com/symbol/GRUB' title='GrubHub Inc.'>GRUB</a>) <font color='red'>slipped 3.9%</font> today, giving back some of yesterday's <font color='green'>27% gain</font> spurred by an <a href=\"https://seekingalpha.com/news/3329319-yum-brands-grubhub-announce-strategic-partnership\" target=\"_blank\">investment from Yum Brands</a>.</li>    <li>The stock move resulted in nearly a dozen price target hikes from prominent analysts -- not necessarily all bulls. KeyBanc raised its target to what looks to be a Street high of $105, implying 23% upside from today's closing price. GrubHub closed at $85.54 today.</li>    <li>Meanwhile, Susquehanna raised its target to $87 but stayed Neutral on valuation concerns. Credit Suisse stuck with a Neutral position while raising its target to $80.</li>    <li>And Monness Crespi Hardt stayed with its Sell rating, though it raised target price to $65 from $52, now implying just 24% downside.</li>    <li>Analyst James Cakmak gave <a href=\"https://www.barrons.com/articles/grubhub-credit-and-caution-from-a-bear-1518191763?mod=yahoobarrons&amp;ru=yahoo&amp;yptr=yahoo\" target=\"_blank\">credit where it's due</a>, saying \"Our thesis has largely been predicated on increasing encroachment into the food category from tech bellwethers where restaurant allegiances are based on the broadest network with the most competitive rates ... Grub has figured out how to stay relevant in an ever-crowding space.&rdquo;</li>    <li>But valuation is \"beyond stretched\" now: &ldquo;Even giving the full benefit of the doubt with a premium multiple leaves the shares still overvalued.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3330013\" data-linked=\"Analysts boost targets on GrubHub after Yum infusion\" data-tweet=\"$GRUB - Analysts boost targets on GrubHub after Yum infusion https://seekingalpha.com/news/3330013-analysts-boost-targets-on-grubhub-after-yum-infusion?source=tweet\" data-url=\"https://seekingalpha.com/news/3330013-analysts-boost-targets-on-grubhub-after-yum-infusion\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330004\" data-ts=\"1518214418\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QUMU\" target=\"_blank\">QUMU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330004-qumu-announces-preliminary-q4-year-end-results-sharesminus-2_25-ah\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qumu announces Preliminary Q4 &amp; year end results; shares -2.25% AH</a></h4><ul>     <li>Qumu Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/QUMU' title='Qumu Corporation'>QUMU</a>) expects Q4 revenue in the range of $7.0M - $7.4M {prior guidance: $8.5M - $9.5M} vs. a consensus of $9.07M.</li>     <li>Q4 EPS is expected to be in the range of $(0.38) - $(0.34) {prior guidance: $(0.15) - $(0.10)} vs. a consensus of $(0.13).</li>     <li>The company expects FY17 revenue in the range of $28M - $28.4M {prior: $29.4M - $30.4M}&nbsp; vs. a consensus of $30M.</li>     <li>FY17 EPS in the range $(1.29) - $(1.25) {prior: $(1.05) - $(1.0)} vs. a consensus of $(1.04).</li>     <li>Net loss per diluted share for the Q4 &amp; FY17 reflects $1.5M, or ~$0.16/share, of interest expense in connection with the incremental amortization of deferred financing costs related to modification of the Company&rsquo;s term note agreement during the Q417.</li>     <li>The Company will provide final Q4 &amp; year end 2017 results on March 6, 2018.</li><li>Shares&nbsp;<font color='red'>-2.25% AH</font></li>     <li><a href=\"https://seekingalpha.com/pr/17071179-qumu-announces-preliminary-fourth-quarter-year-end-2017-results\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3330004\" data-linked=\"Qumu announces Preliminary Q4 &amp; year end results; shares -2.25% AH\" data-tweet=\"$QUMU - Qumu announces Preliminary Q4 &amp; year end results; shares -2.25% AH https://seekingalpha.com/news/3330004-qumu-announces-preliminary-q4-year-end-results-sharesminus-2_25-ah?source=tweet\" data-url=\"https://seekingalpha.com/news/3330004-qumu-announces-preliminary-q4-year-end-results-sharesminus-2_25-ah\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329989\" data-ts=\"1518211728\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329989-weekly-etf-gainers-losers-2-9-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weekly ETF Gainers / Losers (2/9/18)</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/VXX' title='iPath S&P 500 VIX Short-Term Futures ETN'>VXX</a> <font color='green'>+52.0%</font>. <a href='https://seekingalpha.com/symbol/UUP' title='PowerShares DB USD Bull ETF'>UUP</a> <font color='green'>+1.5%</font>. <a href='https://seekingalpha.com/symbol/FXY' title='Guggenheim CurrencyShares Japanese Yen Trust ETF'>FXY</a> <font color='green'>+1.3%</font>. <a href='https://seekingalpha.com/symbol/PGF' title='PowerShares Financial Preferred Portfolio ETF'>PGF</a> <font color='green'>+0.4%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/OIL' title='iPath S&P Crude Oil Total Return Index ETN'>OIL</a> <font color='red'>-11.8%</font>. <a href='https://seekingalpha.com/symbol/FXI' title='iShares China Large-Cap ETF'>FXI</a> <font color='red'>-9.7%</font>. <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a> <font color='red'>-9.1%</font>. <a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a> <font color='red'>-9.0%</font>. <a href='https://seekingalpha.com/symbol/FCG' title='First Trust Natural Gas ETF'>FCG</a> <font color='red'>-8.8%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329989\" data-linked=\"Weekly ETF Gainers / Losers (2/9/18)\" data-tweet=\"$VXX $UUP $FXY - Weekly ETF Gainers / Losers (2/9/18) https://seekingalpha.com/news/3329989-weekly-etf-gainers-losers-2-9-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3329989-weekly-etf-gainers-losers-2-9-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329978\" data-ts=\"1518209549\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TROV\" target=\"_blank\">TROV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329978-trovagenes-pcmminus-075-shows-encouraging-action-in-preclinical-testing-shares-up-22\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Trovagene&#39;s PCM-075 shows encouraging action in preclinical testing; shares up 22%</a></h4><ul><li>Nano cap Trovagene (<a href='https://seekingalpha.com/symbol/TROV' title='TrovaGene, Inc.'>TROV</a> <font color='green'>+21.8%</font>) is up on more than triple normal volume on the heels of its <a href=\"https://seekingalpha.com/pr/17071090-trovagene-presents-data-showing-synergy-pcmminus-075-combination-zytiga-castration-resistant\" target=\"_blank\">announcement </a>of encouraging preclinical data on candidate PCM-075. The data were presented at the ASCO GU Symposium in San Francisco.</li><li>The data showed a synergistic effect from the combination of PCM-075 and Johnson &amp; Johnson's ZYTIGA (abiraterone acetate) in prostate cancer cell lines.</li><li>A Phase 2 clinical trial evaluating the combination in patients with metastatic castration-resistant prostate cancer was initiated last month.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3324828-trovagene-launches-mid-stage-study-pmcminus-075-zytiga-combo-mcrpc\" target=\"_blank\">Trovagene launches mid-stage study of PMC-075/Zytiga combo in mCRPC</a> (Jan. 24)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329978\" data-linked=\"Trovagene&#39;s PCM-075 shows encouraging action in preclinical testing; shares up 22%\" data-tweet=\"$TROV - Trovagene&#39;s PCM-075 shows encouraging action in preclinical testing; shares up 22% https://seekingalpha.com/news/3329978-trovagenes-pcmminus-075-shows-encouraging-action-in-preclinical-testing-shares-up-22?source=tweet\" data-url=\"https://seekingalpha.com/news/3329978-trovagenes-pcmminus-075-shows-encouraging-action-in-preclinical-testing-shares-up-22\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:52 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329977\" data-ts=\"1518209140\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NGL\" target=\"_blank\">NGL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329977-ngl-energy-partnersminus-17-quarterly-results-propped-up-asset-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">NGL Energy Partners -17% as quarterly results propped up by asset sale</a></h4><ul>     <li>NGL&nbsp;Energy Partners (<a href='https://seekingalpha.com/symbol/NGL' title='NGL Energy Partners LP'>NGL</a> <font color='red'>-17.5%</font>) plunges despite reporting <a href=\"https://seekingalpha.com/news/3329847-ngl-energy-partners-eps-0_32\" target=\"_blank\">FQ3 earnings</a> that appeared to exceed analyst expectations as well as a 31% Y/Y increase in revenue to $4.46B.</li>     <li>NGL's quarterly net income of $56.8M included the gain on the $108.6M sale of its 50% interest in Glass Mountain Pipeline, compared to year-ago net income of $1.3M.</li>     <li>NGL says distributable cash flow in the quarter fell 20% Y/Y to $60.7M from $76M in the prior-year quarter.</li>     <li>The Crude Oil Logistics segment generated adjusted EBITDA of $30.3M during the quarter vs. $16.6M a year ago; the Grand Mesa pipeline  contributed $43.2M in adjusted EBITDA as physical volumes averaged ~100K bbl/day.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329977\" data-linked=\"NGL Energy Partners -17% as quarterly results propped up by asset sale\" data-tweet=\"$NGL - NGL Energy Partners -17% as quarterly results propped up by asset sale https://seekingalpha.com/news/3329977-ngl-energy-partnersminus-17-quarterly-results-propped-up-asset-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3329977-ngl-energy-partnersminus-17-quarterly-results-propped-up-asset-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329976\" data-ts=\"1518208967\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOX\" target=\"_blank\">FOX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329976-comcast-ceo-plans-5b-plus-in-buybacks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Comcast CEO plans $5B-plus in buybacks</a></h4><ul>   <li>Speaking about free cash flow in the wake of tax reform, Comcast (<a href=\"http://seekingalpha.com/symbol/CMCSA\" target=\"_blank\">CMCSA</a> <font color='green'>+0.3%</font>) Chairman/CEO Brian Roberts says the company will repurchase at least $5B in stock as a result.</li>    <li>\"We've said we wanted to change the target leverage to actually be a <a href=\"https://finance.yahoo.com/video/comcast-ceo-well-least-5-145400988.html\" target=\"_blank\">little bit higher than we've previously said</a>,\" Roberts says. \"So we've talked about 2.2x, previously we've been 1.5 to 2 ... so that's an increase which would suggest that we could do more buybacks.</li>    <li>\"So we do at least a $5B stock buyback, we increase the dividend 21% ... We want to invest in the business, first and foremost, but we also return to shareholders.\"</li>    <li>Roberts adds in the segment that he'll miss Thursday Night Football, now <a href=\"https://seekingalpha.com/news/3327121-fox-turns-lower-locking-thursday-nfl-3b\" target=\"_blank\">moving to a much-higher-bidding Fox</a> (<a href='https://seekingalpha.com/symbol/FOX' title='Twenty-First Century Fox, Inc.'>FOX</a> <font color='green'>+2.9%</font>, <a href='https://seekingalpha.com/symbol/FOXA' title='Twenty-First Century Fox, Inc.'>FOXA</a> <font color='green'>+2.8%</font>), but: \"We said when we bought NBCUniversal that we wanted to be financially disciplined with sports. That hadn't always been the case.</li>    <li>\"And we are sorry to lose it ... We have Sunday night football, which is the No. 1 show on television, and we have that for many more years.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329976\" data-linked=\"Comcast CEO plans $5B-plus in buybacks\" data-tweet=\"$FOX $FOX $FOXA - Comcast CEO plans $5B-plus in buybacks https://seekingalpha.com/news/3329976-comcast-ceo-plans-5b-plus-in-buybacks?source=tweet\" data-url=\"https://seekingalpha.com/news/3329976-comcast-ceo-plans-5b-plus-in-buybacks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:42 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329972\" data-ts=\"1518207650\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VXRT\" target=\"_blank\">VXRT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329972-aviragen-not-quite-shareholder-support-for-vaxart-tie-up-shares-down-4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aviragen not quite there with shareholder support for Vaxart tie-up; shares down 4%</a></h4><ul><li>Aviragen Therapeutics (AVIR <font color='red'>-3.8%</font>) has <a href=\"https://seekingalpha.com/pr/17071062-aviragen-adjourns-special-meeting-stockholders-allow-stockholders-consider-improved-merger\" target=\"_blank\">postponed </a>its February 13 special shareholders meeting in order to \"provide [its] stockholders additional time to consider the revised deal terms\" related to its proposed merger with Vaxart.</li><li>Under the terms of the original agreement, Aviragen shareholders would own ~40% of the combined company. Under the revised deal, <a href=\"https://www.sec.gov/Archives/edgar/data/72444/000143774918001951/avir20180207_8k.htm\" target=\"_blank\">reported</a> two days ago, Aviragen shareholders would own 49% of the combined firm.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3305521-aviragen-merge-vaxart\" target=\"_blank\">Aviragen to merge with Vaxart</a> (Oct. 30, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329972\" data-linked=\"Aviragen not quite there with shareholder support for Vaxart tie-up; shares down 4%\" data-tweet=\"$VXRT - Aviragen not quite there with shareholder support for Vaxart tie-up; shares down 4% https://seekingalpha.com/news/3329972-aviragen-not-quite-shareholder-support-for-vaxart-tie-up-shares-down-4?source=tweet\" data-url=\"https://seekingalpha.com/news/3329972-aviragen-not-quite-shareholder-support-for-vaxart-tie-up-shares-down-4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329968\" data-ts=\"1518206648\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MELI\" target=\"_blank\">MELI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329968-mercadolibre-falls-on-amazon-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MercadoLibre falls on Amazon concerns</a></h4><ul>     <li>Shares of MercadoLibre (NASDAQ:<a href='https://seekingalpha.com/symbol/MELI' title='MercadoLibre, Inc.'>MELI</a>) are <font color='red'>down 2.9%</font> after Reuters <a href=\"https://www.reuters.com/article/us-amazon-brazil-exclusive/exclusive-amazon-eyes-new-warehouse-in-brazil-e-commerce-push-sources-idUSKBN1FT2HM\" target=\"_blank\">reports</a> that Amazon is making a move to lease a huge warehouse outside of Sao Paulo.</li>     <li>Sources indicates that Amazon may be looking to handle distribution in Brazil of products purchased off its site.</li>     <li>\"It&rsquo;s another signal that Amazon&rsquo;s push into Latin America is serious,\" observes Allaria Ledesma analyst Julia Ayzaguer on the development (per Bloomberg).</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3329968\" data-linked=\"MercadoLibre falls on Amazon concerns\" data-tweet=\"$MELI - MercadoLibre falls on Amazon concerns https://seekingalpha.com/news/3329968-mercadolibre-falls-on-amazon-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3329968-mercadolibre-falls-on-amazon-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:04 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329966\" data-ts=\"1518206119\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INPX\" target=\"_blank\">INPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329966-technology-top-gainers-losers-of-2_55-pm-2-9-18\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2.55 pm (2/9/18)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='green'>+23%</font>. <a href='https://seekingalpha.com/symbol/MOBL' title='MobileIron, Inc.'>MOBL</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/PCYG' title='Park City Group, Inc.'>PCYG</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/UIS' title='Unisys Corporation'>UIS</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/INVA' title='Innoviva, Inc.'>INVA</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/WEB' title='Web.com Group, Inc'>WEB</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/SWIR' title='Sierra Wireless, Inc.'>SWIR</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/PSDO' title='Presidio'>PSDO</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/HDP' title='Hortonworks'>HDP</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='red'>-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329966\" data-linked=\"Technology - Top Gainers / Losers as of 2.55 pm (2/9/18)\" data-tweet=\"$INPX $INPX $MOBL - Technology - Top Gainers / Losers as of 2.55 pm (2/9/18) https://seekingalpha.com/news/3329966-technology-top-gainers-losers-of-2_55-pm-2-9-18?source=tweet\" data-url=\"https://seekingalpha.com/news/3329966-technology-top-gainers-losers-of-2_55-pm-2-9-18\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329963\" data-ts=\"1518205442\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329963-amazon-studios-hires-nbc-entertainment-president\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon Studios hires NBC Entertainment president</a></h4><ul><li>        Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) <a href=\"https://www.hollywoodreporter.com/news/nbcs-jennifer-salke-lands-top-job-at-amazon-studios-1083032\" target=\"_blank\">hires</a> NBC Entertainment president Jennifer Salke to run Amazon Studios.</li><li>               Salke will replace interim studio chief Albert Cheng.&nbsp;</li><li>               Former Amazon Studios head Roy Price left in October after a sexual harassment allegation. &nbsp;&nbsp;</li><li>               Amazon shares are&nbsp;<font color='red'>down 2%</font>.&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329802-amazon-shadow-sends-fedex-ups-lower\" target=\"_blank\">Amazon shadow sends FedEx and UPS lower</a> (Feb. 9)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329944-reuters-amazon-planning-brazilian-mega-warehouse\" target=\"_blank\">Reuters: Amazon planning Brazilian mega-warehouse</a> (Feb. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329963\" data-linked=\"Amazon Studios hires NBC Entertainment president\" data-tweet=\"$AMZN - Amazon Studios hires NBC Entertainment president https://seekingalpha.com/news/3329963-amazon-studios-hires-nbc-entertainment-president?source=tweet\" data-url=\"https://seekingalpha.com/news/3329963-amazon-studios-hires-nbc-entertainment-president\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329984\" data-ts=\"1518204956\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FE\" target=\"_blank\">FE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329984-bloomberg-trump-administration-weighing-aid-for-firstenergy-coal-plants\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Trump administration weighing aid for FirstEnergy coal plants</a></h4><ul>     <li>FirstEnergy (<a href='https://seekingalpha.com/symbol/FE' title='FirstEnergy Corp'>FE</a> <font color='green'>+2.1%</font>) is higher after Bloomberg reports U.S. Energy Secretary Perry is <a href=\"https://www.bloomberg.com/news/articles/2018-02-09/rick-perry-is-said-to-be-weighing-another-way-to-save-coal-units\" target=\"_blank\">considering using his authority under Section 202</a> of the Federal Power Act to order coal plants run by  FE to remain online &ldquo;to serve the public interest.\"</li>     <li>The Trump administration last year declined a request from FE and its main supplier, privately owned coal miner Murray Energy, to use the emergency powers to stop coal plants from closing.</li>     <li>But Perry may be reconsidering, according to the report, after the Federal Energy Regulatory Commission denied his request to subsidize struggling coal and nuclear plants to reward them for their ability to store energy for 90 days on-site.</li>     <li>Spokespeople at both FE and Murray Energy said they were unaware of any impending action but would welcome the support.</li>     <li>FE coal-fired plants at risk of closure include Bruce Mansfield in Shippingport, Pa., and W.H. Sammis in Stratton, Ohio.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329984\" data-linked=\"Bloomberg: Trump administration weighing aid for FirstEnergy coal plants\" data-tweet=\"$FE - Bloomberg: Trump administration weighing aid for FirstEnergy coal plants https://seekingalpha.com/news/3329984-bloomberg-trump-administration-weighing-aid-for-firstenergy-coal-plants?source=tweet\" data-url=\"https://seekingalpha.com/news/3329984-bloomberg-trump-administration-weighing-aid-for-firstenergy-coal-plants\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:35 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329960\" data-ts=\"1518203866\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329960-stocks-bounce-back-from-abyss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks bounce back from abyss</a></h4><ul><li>A few minutes ago, it looked like another 1K point down day was in the making, but another major reversal has the averages modestly higher, led by the S&amp;P 500's&nbsp;<font color='green'>0.4% advance</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329960\" data-linked=\"Stocks bounce back from abyss\" data-tweet=\"Stocks bounce back from abyss https://seekingalpha.com/news/3329960-stocks-bounce-back-from-abyss?source=tweet\" data-url=\"https://seekingalpha.com/news/3329960-stocks-bounce-back-from-abyss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>111&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329958\" data-ts=\"1518202857\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CGG-OLD\" target=\"_blank\">CGG-OLD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329958-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CGG-OLD' title='CGG'>CGG-OLD</a> <font color='green'>+25%</font>. <a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/NGL' title='NGL Energy Partners LP'>NGL</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/FET' title='Forum Energy Technologies'>FET</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/JONE' title='Jones Energy, Inc.'>OTC:JONE</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/MCEP' title='Mid-Con Energy Partners'>MCEP</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/MCF' title='Contango Oil & Gas Company'>MCF</a> <font color='red'>-12%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329958\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$CGG-OLD $CGG-OLD $IO - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3329958-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3329958-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3330014\" data-ts=\"1518202092\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FET\" target=\"_blank\">FET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3330014-forum-energy-techminus-15-on-q4-miss-guides-q1-revenues-below-consensus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Forum Energy Tech -15% on Q4 miss, guides Q1 revenues below consensus</a></h4><ul>     <li>Forum Energy Technologies (<a href='https://seekingalpha.com/symbol/FET' title='Forum Energy Technologies'>FET</a> <font color='red'>-15.6%</font>) plunges 15% after posting a slightly larger than expected<a href=\"https://seekingalpha.com/news/3329729-forum-energy-reports-q4-results\" target=\"_blank\"> Q4 loss</a> but guiding Q1 revenues below consensus.</li>     <li>FET says Q4 revenues rose 68% Y/Y to $247.7M but slightly missed the $249.8M analyst consensus estimate, and new orders received in the quarter came in flat at $232M.</li>     <li>FET forecasts Q1 revenues of $240M-$255M, below the $258.8M analyst consensus, and sees EBITDA of $18M-$23M.</li><li>\"Although customer spending is off to a slow start in January, we expect activity to accelerate throughout the year,\" the company says.</li></ul><div class=\"tiny-share-widget\" data-id=\"3330014\" data-linked=\"Forum Energy Tech -15% on Q4 miss, guides Q1 revenues below consensus\" data-tweet=\"$FET - Forum Energy Tech -15% on Q4 miss, guides Q1 revenues below consensus https://seekingalpha.com/news/3330014-forum-energy-techminus-15-on-q4-miss-guides-q1-revenues-below-consensus?source=tweet\" data-url=\"https://seekingalpha.com/news/3330014-forum-energy-techminus-15-on-q4-miss-guides-q1-revenues-below-consensus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:48 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329953\" data-ts=\"1518201477\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PFLT\" target=\"_blank\">PFLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329953-management-offers-take-pennantpark-floating-tumbles-post-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Management offers its take as PennantPark Floating tumbles post-earnings</a></h4><ul><li>FQ1 net investment loss of $1.9M or $0.05 per share vs. income of $10.4M and $0.32 in FQ4. FQ1's result include $0.29 per share in credit facility amendment and debt issuance costs. Core NII per share came in at $0.25. Distributions were $0.285.</li><li>Dec. 31 net asset value per share of $13.86 slips from $14.10 three months earlier.</li><li>$176.9M put to work during quarter vs. $101.1M in FQ4. Sales and repayments of $149.1M vs. $91.7M in FQ4.</li><li>Conference call participants were able in real time to get management's reaction to the sharp decline in the stock (<a href=\"https://seekingalpha.com/article/4145126-pennantpark-floating-rate-capitals-pflt-ceo-art-penn-q1-2018-results-earnings-call-transcript?part=single\" target=\"_blank\">transcript here</a>). CEO Art Penn says the quarter may be looking ugly as the company more or less re-jiggered the entire liability side of its balance sheet last quarter. The GAAP hit should be worth it though, says Penn, as the company locked in a low interest rate, and should have lower interest expenses than peers going forward.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329578-pennantpark-misses-0_01-misses-net-investment-income\" target=\"_blank\">PennantPark misses by $0.01, misses on net investment income</a> (Feb. 8)</li><li><a href='https://seekingalpha.com/symbol/PFLT' title='PennantPark Floating Rate Capital'>PFLT</a>&nbsp;<font color='red'>-7%</font></li></ul><div class=\"tiny-share-widget\" data-id=\"3329953\" data-linked=\"Management offers its take as PennantPark Floating tumbles post-earnings\" data-tweet=\"$PFLT - Management offers its take as PennantPark Floating tumbles post-earnings https://seekingalpha.com/news/3329953-management-offers-take-pennantpark-floating-tumbles-post-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3329953-management-offers-take-pennantpark-floating-tumbles-post-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329946\" data-ts=\"1518201000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FMNB\" target=\"_blank\">FMNB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329946-financials-top-5-gainers-losers-of-1-30-pm-02-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:30 PM (02/09/2018)</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/FMNB' title='Farmers National Banc Corp.'>FMNB</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SSFN' title='Stewardship Financial Corp'>SSFN</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/JTPY' title='JetPay Corporation'>JTPY</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/ARCT' title='Arcturus Therapeutics Ltd.'>ARCT</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WPG' title='Washington Prime Group, Inc.'>WPG</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/AMRK' title='A-Mark Precious Metals, Inc.'>AMRK</a> <font color='red'>-8%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329946\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:30 PM (02/09/2018)\" data-tweet=\"$FMNB $FMNB $SSFN - Financials - Top 5 Gainers / Losers as of 1:30 PM (02/09/2018) https://seekingalpha.com/news/3329946-financials-top-5-gainers-losers-of-1-30-pm-02-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3329946-financials-top-5-gainers-losers-of-1-30-pm-02-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:30 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329944\" data-ts=\"1518200513\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329944-reuters-amazon-planning-brazilian-mega-warehouse\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Amazon planning Brazilian mega-warehouse</a></h4><ul><li>        Amazon (<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a> <font color='red'>-4%</font>) wants to lease a 50K-square-meter warehouse near Sao Paulo, Brazil, according to <a href=\"https://www.reuters.com/article/us-amazon-brazil-exclusive/exclusive-amazon-eyes-new-warehouse-in-brazil-e-commerce-push-sources-idUSKBN1FT2HM\" target=\"_blank\">Reuters sources</a>.</li><li>               Logistics company Prologis (<a href='https://seekingalpha.com/symbol/PLD' title='Prologis'>PLD</a> <font color='green'>+0.5%</font>) reportedly offered the space to Amazon. The two previously teamed up on a warehouse in Mexico.&nbsp;</li><li>               The investment would be quadruple the size of the Amazon&rsquo;s current Brazilian operation, which suggests the retailer might soon move beyond books and electronics to distributing other goods in the country.&nbsp;</li><li>               E-commerce accounts for about 5% of Brazil&rsquo;s $300B retail market but that share has doubled in the last four years. Analysts expect a continued double-digit annual growth.&nbsp;</li><li>                  Amazon first started selling electronics in the region last October.    </li><li>               Competitors: Mercado Libre (<a href='https://seekingalpha.com/symbol/MELI' title='MercadoLibre, Inc.'>MELI</a> <font color='red'>-5.1%</font>) and B2w Chia Digital.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329802-amazon-shadow-sends-fedex-ups-lower\" target=\"_blank\">Amazon shadow sends FedEx and UPS lower</a> (Feb. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329944\" data-linked=\"Reuters: Amazon planning Brazilian mega-warehouse\" data-tweet=\"$AMZN $AMZN $PLD - Reuters: Amazon planning Brazilian mega-warehouse https://seekingalpha.com/news/3329944-reuters-amazon-planning-brazilian-mega-warehouse?source=tweet\" data-url=\"https://seekingalpha.com/news/3329944-reuters-amazon-planning-brazilian-mega-warehouse\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329943\" data-ts=\"1518200275\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329943-sell-side-bulls-defend-sarepta-after-trial-suspension-stoked-drop-shares-down-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sell-side bulls defend Sarepta after trial suspension-stoked drop, shares down 10%</a></h4><ul><li>Sell-side supporters of Sarepta Therapeutics (<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a> <font color='red'>-9.7%</font>) rush to defend the stock after an ugly down move today triggered by a report that its Phase 3 clinical trial assessing DMD candidate golodirsen (SRP-4045) has been put on temporary hold due to a safety signal. The bearish action only adds to longs' anxiety considering the stock's&nbsp;<font color='red'>25%</font>&nbsp;slump since touching $68.90 on January 26.</li><li>JPMorgan's Anupam Rama, Goldman's Salveen Richter and Leerink's Joseph Schwartz all say the trial halt is nothing to worry about. Mr. Rama adds that the participant who developed rhabdomyolysis has resumed dosing.</li><li>All rate the stock a BUY with price targets ranging from $63 to $77.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329829-sarepta-slips-7-percent-premarket-golodirsen-study-halt\" target=\"_blank\">Sarepta slips 7% premarket on golodirsen study halt</a> (Feb. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329943\" data-linked=\"Sell-side bulls defend Sarepta after trial suspension-stoked drop, shares down 10%\" data-tweet=\"$SRPT - Sell-side bulls defend Sarepta after trial suspension-stoked drop, shares down 10% https://seekingalpha.com/news/3329943-sell-side-bulls-defend-sarepta-after-trial-suspension-stoked-drop-shares-down-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3329943-sell-side-bulls-defend-sarepta-after-trial-suspension-stoked-drop-shares-down-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329939\" data-ts=\"1518199411\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HDP\" target=\"_blank\">HDP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329939-cowen-adjusts-hortonworks-target-after-earnings-cites-weak-fy-rev-guide\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cowen adjusts Hortonworks target after earnings, cites weak FY rev. guide</a></h4><ul><li>        Cowen reiterates its Market Perform rating on Hortonworks (NASDAQ:<a href='https://seekingalpha.com/symbol/HDP' title='Hortonworks'>HDP</a>) but raises the price target by a dollar to $19, which is $0.16 above yesterday&rsquo;s closing price.</li><li>               Analyst J. Derrick Wood writes that the company made strides to improve FCF, but it remains an &ldquo;overhang on valuation.&rdquo;&nbsp;</li><li>               Wood remains on the sidelines due to the minimal FCF leverage and generation for FY18 and weaker billings trend visibility.&nbsp;</li><li>               The analyst notes that adopting the ASC 606 account standards created a $15M headwind for Hortonworks with revenue projected to grow 25% compared to the 42% growth last year.&nbsp;</li><li>               Source: Bloomberg First Word.&nbsp;</li><li>               Hortonworks shares are&nbsp;<font color='red'>down 9.5%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329695-hortonworks-reports-q4-revenue-beat-upside-guidance\" target=\"_blank\">Hortonworks reports Q4 revenue beat, upside guidance</a> (Feb. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329939\" data-linked=\"Cowen adjusts Hortonworks target after earnings, cites weak FY rev. guide\" data-tweet=\"$HDP - Cowen adjusts Hortonworks target after earnings, cites weak FY rev. guide https://seekingalpha.com/news/3329939-cowen-adjusts-hortonworks-target-after-earnings-cites-weak-fy-rev-guide?source=tweet\" data-url=\"https://seekingalpha.com/news/3329939-cowen-adjusts-hortonworks-target-after-earnings-cites-weak-fy-rev-guide\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329936\" data-ts=\"1518198914\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMG\" target=\"_blank\">CMG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329936-bruising-week-continues-for-chipotle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bruising week continues for Chipotle</a></h4><ul> <li>Negative analyst commentary continues to linger over Chipotle (<a href='https://seekingalpha.com/symbol/CMG' title='Chipotle Mexican Grill, Inc.'>CMG</a> <font color='red'>-6.3%</font>).</li> <li>The latest into the fray is Cowen, with a new warning on sales trend based in part off of Facebook check-ins data. Analyst Andrew Charles now forecasts Q1 same-stores sales growth of +0.5% vs. +1.3% consensus and +0.5% to +1.5% CMG guidance.</li> <li>Shares are Chipotle are down ~20% for the week.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3328616-chipotle-showing-margin-improvement\" target=\"_blank\">Chipotle up after showing margin improvement</a> (Feb. 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3328833-chipotle-exec-talks-potential-analysts-take-estimates\" target=\"_blank\">Chipotle exec talks up potential, analysts take down estimates</a> (Feb. 7)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3329936\" data-linked=\"Bruising week continues for Chipotle\" data-tweet=\"$CMG - Bruising week continues for Chipotle https://seekingalpha.com/news/3329936-bruising-week-continues-for-chipotle?source=tweet\" data-url=\"https://seekingalpha.com/news/3329936-bruising-week-continues-for-chipotle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329934\" data-ts=\"1518198389\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INPX\" target=\"_blank\">INPX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329934-midday-gainers-losers-2-9-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers (2/9/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='green'>+32%</font>. AOI <font color='green'>+28%</font>. <a href='https://seekingalpha.com/symbol/CGG-OLD' title='CGG'>CGG-OLD</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/WAIR' title='Wesco Aircraft Holdings'>WAIR</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/IO' title='ION Geophysical Corporation'>IO</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/MOBL' title='MobileIron, Inc.'>MOBL</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/UIS' title='Unisys Corporation'>UIS</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/PCYG' title='Park City Group, Inc.'>PCYG</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/AQXP' title='Aquinox Pharmaceuticals, Inc.'>AQXP</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MCFT' title='MasterCraft Boat Holdings, Inc.'>MCFT</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a> <font color='red'>-22%</font>. <a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-20%</font>. <a href='https://seekingalpha.com/symbol/EXPE' title='Expedia, Inc.'>EXPE</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/RMGN' title='RMG Networks'>RMGN</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/WEB' title='Web.com Group, Inc'>WEB</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/CTXR' title='Citius Pharmaceuticals Inc.'>CTXR</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/NGL' title='NGL Energy Partners LP'>NGL</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/SWIR' title='Sierra Wireless, Inc.'>SWIR</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/CIVI' title='Civitas Solutions'>CIVI</a> <font color='red'>-17%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329934\" data-linked=\"Midday Gainers / Losers (2/9/2018)\" data-tweet=\"$INPX $INPX $PYX - Midday Gainers / Losers (2/9/2018) https://seekingalpha.com/news/3329934-midday-gainers-losers-2-9-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3329934-midday-gainers-losers-2-9-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329930\" data-ts=\"1518197660\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GPP\" target=\"_blank\">GPP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329930-green-plains-partners-higher-after-stifel-upgrades-to-buy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Green Plains Partners higher after Stifel upgrades to Buy</a></h4><ul>     <li>Green Plains Partners (<a href='https://seekingalpha.com/symbol/GPP' title='Green Plains Partners'>GPP</a> <font color='green'>+1.5%</font>) is upgraded to Buy from Hold with a $20 price target at Stifel following better than expected <a href=\"https://seekingalpha.com/news/3329072-green-plains-partners-beats-0_02-beats-revenue\" target=\"_blank\">Q4 earnings</a>.</li>     <li>Stifel notes GPP management reiterated its desire to expand the asset base beyond assets affiliated with Green Plains Inc. (<a href='https://seekingalpha.com/symbol/GPRE' title='Green Plains Inc.'>GPRE</a> <font color='red'>-2.5%</font>) and highlighted a goal of 25% of revenues being non affiliated with GPRE in the next 18 months.</li>     <li>As such, Stifel thinks GPP could invest in additional terminals that blend ethanol in various markets, adding that management previously has said a terminal delivering E-15 to local markets would have appeal.</li>     <li>Source:&nbsp;Briefing.com</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329930\" data-linked=\"Green Plains Partners higher after Stifel upgrades to Buy\" data-tweet=\"$GPP $GPP $GPRE - Green Plains Partners higher after Stifel upgrades to Buy https://seekingalpha.com/news/3329930-green-plains-partners-higher-after-stifel-upgrades-to-buy?source=tweet\" data-url=\"https://seekingalpha.com/news/3329930-green-plains-partners-higher-after-stifel-upgrades-to-buy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329929\" data-ts=\"1518197497\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AONNY\" target=\"_blank\">AONNY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329929-softbank-yahoo-japan-aeon-team-on-online-retail-venture\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">SoftBank, Yahoo Japan, Aeon team on online retail venture</a></h4><ul>   <li>SoftBank (<a href=\"http://seekingalpha.com/symbol/SFTBY\" target=\"_blank\">SFTBY</a> <font color='green'>+2.1%</font>) is coming together with Yahoo Japan (<a href=\"http://seekingalpha.com/symbol/YAHOY\" target=\"_blank\">YAHOY</a> <font color='green'>+1.1%</font>) and Aeon (<a href='https://seekingalpha.com/symbol/AONNY' title='Aeon Co. Ltd. ADR'>OTCPK:AONNY</a>) to launch an <a href=\"https://finance.yahoo.com/news/softbank-yahoo-japan-aeon-plan-044857435.html\" target=\"_blank\">online retail business</a> to combat growing competition from Amazon.com, according to NHK.</li>    <li>The venture would sell products including food, clothes and everyday goods and combines Aeon's product range and distribution with deep customer knowledge from SoftBank and Yahoo Japan.</li>    <li>Amazon has been testing its Fresh food delivery in parts of Tokyo, part of a gradually increasing range of services in Japan.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3325600-walmart-partners-rakuten\" target=\"_blank\">Walmart partners up with Rakuten</a> (Jan. 26 2018)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329929\" data-linked=\"SoftBank, Yahoo Japan, Aeon team on online retail venture\" data-tweet=\"$AONNY $AONNY $SFTBY - SoftBank, Yahoo Japan, Aeon team on online retail venture https://seekingalpha.com/news/3329929-softbank-yahoo-japan-aeon-team-on-online-retail-venture?source=tweet\" data-url=\"https://seekingalpha.com/news/3329929-softbank-yahoo-japan-aeon-team-on-online-retail-venture\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329928\" data-ts=\"1518197000\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329928-another-sharp-drop-in-oil-and-energy-names-leads-markets-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another sharp drop in oil and energy names leads markets lower</a></h4><ul><li>WTI crude oil is&nbsp;<font color='red'>down another 3.2%</font>&nbsp;today, now&nbsp;<font color='red'>off about 20%</font>&nbsp;in the last handful of sessions, and slipping below $60 per barrel for the first time this year. <a href='https://seekingalpha.com/symbol/USO' title='The United States Oil ETF, LP'>USO</a>&nbsp;<font color='red'>-1.65%</font>.</li><li>Alongside, the energy sector (<a href='https://seekingalpha.com/symbol/XLE' title='Energy Select Sector SPDR ETF'>XLE</a> <font color='red'>-1.9%</font>) is leading the major averages into negative territory. Things are highly volatile though, and a turn into the green at any moment shouldn't surprise.</li><li>The S&amp;P 500 is&nbsp;<font color='red'>off 0.5%</font>&nbsp;and the Dow&nbsp;<font color='red'>0.9%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329928\" data-linked=\"Another sharp drop in oil and energy names leads markets lower\" data-tweet=\"$USO $XLE - Another sharp drop in oil and energy names leads markets lower https://seekingalpha.com/news/3329928-another-sharp-drop-in-oil-and-energy-names-leads-markets-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3329928-another-sharp-drop-in-oil-and-energy-names-leads-markets-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:23 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329923\" data-ts=\"1518195842\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYX\" target=\"_blank\">PYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329923-consumer-top-gainers-losers-of-12-00-pm-2-9-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm (2/9/2018)</a></h4><ul>     <li><b>Gainers:</b> AOI <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/MCFT' title='MasterCraft Boat Holdings, Inc.'>MCFT</a> <font color='green'>+15%</font>. <a href='https://seekingalpha.com/symbol/MBUU' title='Malibu Boats, Inc.'>MBUU</a> <font color='green'>+13%</font>. <a href='https://seekingalpha.com/symbol/EVK' title='Ever-Glory International Group, Inc'>EVK</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/SGOC' title='SGOCO Techn'>SGOC</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MPAA' title='Motorcar Parts of America, Inc.'>MPAA</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/LTRPA' title='Liberty TripAdvisor Holdings A'>LTRPA</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/LBIX-OLD' title='Leading Brands Inc'>LBIX-OLD</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/PETZ' title='TDH Holdings, Inc.'>PETZ</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/CSL' title='Carlisle Companies Inc'>CSL</a> <font color='red'>-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329923\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm (2/9/2018)\" data-tweet=\"$PYX $PYX $MCFT - Consumer - Top Gainers / Losers as of 12:00 pm (2/9/2018) https://seekingalpha.com/news/3329923-consumer-top-gainers-losers-of-12-00-pm-2-9-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3329923-consumer-top-gainers-losers-of-12-00-pm-2-9-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329917\" data-ts=\"1518194218\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INSY\" target=\"_blank\">INSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329917-maryland-latest-state-to-jump-on-insys-litigation-bandwagon-shares-down-5\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Maryland latest state to jump on Insys litigation bandwagon; shares down 5%</a></h4><ul><li>The Maryland Attorney General in the <a href=\"https://seekingalpha.com/pr/17070982-insys-therapeutics-addresses-maryland-attorney-general-s-motion\" target=\"_blank\">latest to accuse</a> INSYS Therapeutics (<a href='https://seekingalpha.com/symbol/INSY' title='Insys Therapeutics, Inc.'>INSY</a> <font color='red'>-4.6%</font>) of misbehavior in promoting opioid pain med Subsys (fentanyl). As expected, the company takes issue with the AG's accusations, saying only 101 state residents were prescribed Subsys in 2015, only 0.0016% of the estimated 871K patients who were prescribed an opioid that year.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3327666-insys-takes-issue-ny-ag-suit-alleged-misconduct-subsys-promotion\" target=\"_blank\">INSYS takes issue with NY AG suit over alleged misconduct with Subsys promotion</a> (Feb. 2)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329917\" data-linked=\"Maryland latest state to jump on Insys litigation bandwagon; shares down 5%\" data-tweet=\"$INSY $INSYQ - Maryland latest state to jump on Insys litigation bandwagon; shares down 5% https://seekingalpha.com/news/3329917-maryland-latest-state-to-jump-on-insys-litigation-bandwagon-shares-down-5?source=tweet\" data-url=\"https://seekingalpha.com/news/3329917-maryland-latest-state-to-jump-on-insys-litigation-bandwagon-shares-down-5\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329916\" data-ts=\"1518194028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329916-recode-snap-targets-instagram-advertisers-free-ad-credits\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Recode: Snap targets Instagram advertisers with free ad credits</a></h4><ul>   <li>Snap (<a href=\"http://seekingalpha.com/symbol/SNAP\" target=\"_blank\">SNAP</a> <font color='red'>-2.8%</font>) is engaging in another program to draw advertisers from rivals by <a href=\"https://www.recode.net/2018/2/9/16988784/snap-free-ads-instagram-steal-advertisers\" target=\"_blank\">offering free ad credits</a>, Recode reports.</li>    <li>The company's reaching out to those buying vertical video ads on Instagram (<a href=\"http://seekingalpha.com/symbol/FB\" target=\"_blank\">FB</a> <font color='green'>+0.9%</font>) and others, who are directed to an online application where they can upload proof they bought recently from a Snapchat competitor -- and get ad credits in the range of \"several hundred dollars.\"</li>    <li>Snap tends to sell nearly all vertical video ads through programmatic buying, Recode's Kurt Wagner notes, but with little traffic in the auctions; a bigger pool of advertisers would generate more price competition for the ads.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329916\" data-linked=\"Recode: Snap targets Instagram advertisers with free ad credits\" data-tweet=\"$SNAP $SNAP $FB - Recode: Snap targets Instagram advertisers with free ad credits https://seekingalpha.com/news/3329916-recode-snap-targets-instagram-advertisers-free-ad-credits?source=tweet\" data-url=\"https://seekingalpha.com/news/3329916-recode-snap-targets-instagram-advertisers-free-ad-credits\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>130&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329915\" data-ts=\"1518193676\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SO\" target=\"_blank\">SO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329915-southerns-nuke-power-project-biofuel-producers-get-boost-in-budget-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Southern&#39;s nuke power project, biofuel producers get boost in budget deal</a></h4><ul>     <li>Among the <a href=\"https://www.bloomberg.com/news/articles/2018-02-08/biofuel-producers-nuclear-power-get-boost-in-u-s-budget-deal\" target=\"_blank\">energy incentives in the new budget deal</a> just passed by U.S. lawmakers are ~$2B in tax credits that would benefit Southern Co. (<a href='https://seekingalpha.com/symbol/SO' title='Southern Company'>SO</a> <font color='green'>+0.9%</font>), which is struggling to complete two nuclear reactors in Georgia.</li>     <li>A $1/gallon tax credit for mixing biodiesel is retroactively extended through 2017, an incentive that helps producers such as Renewable Energy Group (<a href='https://seekingalpha.com/symbol/REGI' title='Renewable Energy Group, Inc'>REGI</a> <font color='green'>+4.9%</font>), but Congress did not continue the biodiesel tax credit into the future.</li>     <li>A $1.01/gallon tax credit for the production of cellulosic ethanol also received a retroactive extension through 2017.</li><li>Carbon capture technologies are provided with subsidies to make coal plants able to  compete in a carbon-constrained world. </li>     <li>The deal also calls for <a href=\"https://www.bloomberg.com/news/articles/2018-02-08/u-s-oil-reserve-would-fall-nearly-in-half-under-budget-deal\" target=\"_blank\">selling 100M barrels of oil</a> from the U.S. Strategic Petroleum Reserve by 2027; combined with other sales approved last year, the volume of oil in the SPR would decline by 45% to 303M barrels.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/KOL' title='VanEck Vectors Coal ETF'>KOL</a>, <a href='https://seekingalpha.com/symbol/PBW' title='Invesco WilderHill Clean Energy Portfolio ETF'>PBW</a>, <a href='https://seekingalpha.com/symbol/QCLN' title='First Trust NASDAQ Clean Edge Green Energy Index ETF'>QCLN</a>, <a href='https://seekingalpha.com/symbol/PUW' title='Invesco WilderHill Progressive Energy Portfolio ETF'>PUW</a>, <a href='https://seekingalpha.com/symbol/HECO' title='Huntington Ecological Strategy ETF'>HECO</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3329915\" data-linked=\"Southern&#39;s nuke power project, biofuel producers get boost in budget deal\" data-tweet=\"$SO $SO $REGI - Southern&#39;s nuke power project, biofuel producers get boost in budget deal https://seekingalpha.com/news/3329915-southerns-nuke-power-project-biofuel-producers-get-boost-in-budget-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3329915-southerns-nuke-power-project-biofuel-producers-get-boost-in-budget-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:27 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>30&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329914\" data-ts=\"1518193613\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMGN\" target=\"_blank\">AMGN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329914-biotechs-continue-selloff-xbi-down-almost-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Biotechs continue selloff, XBI down almost 3%</a></h4><ul><li>Buyers of biotech stocks are a scarce commodity as the session approaches the two-hour mark. The SPDR S&amp;P Biotech ETF (<a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a> <font color='red'>-2.7%</font>), for example, has dropped over&nbsp;<font color='red'>13%</font>&nbsp;since touching $97.98 on January 29.</li><li>Selected tickers: (<a href='https://seekingalpha.com/symbol/IBB' title='iShares Nasdaq Biotechnology ETF'>IBB</a> <font color='red'>-1.6%</font>)(<a href='https://seekingalpha.com/symbol/FBT' title='First Trust NYSE Arca Biotechnology Index ETF'>FBT</a> <font color='red'>-0.8%</font>)(<a href='https://seekingalpha.com/symbol/BBH' title='VanEck Vectors Biotech ETF'>BBH</a> <font color='red'>-0.3%</font>)(<a href='https://seekingalpha.com/symbol/BIB' title='ProShares Ultra Nasdaq Biotechnology ETF'>BIB</a> <font color='red'>-2.6%</font>)(<a href='https://seekingalpha.com/symbol/SBIO' title='ALPS Medical Breakthroughs ETF'>SBIO</a> <font color='red'>-2.4%</font>)(<a href='https://seekingalpha.com/symbol/ARKG' title='ARK Genomic Revolution Multi-Sector ETF'>ARKG</a> <font color='red'>-2.3%</font>)(<a href='https://seekingalpha.com/symbol/BBC' title='BioShares Biotechnology Clinical Trials ETF'>BBC</a> <font color='red'>-2.4%</font>)(<a href='https://seekingalpha.com/symbol/BBP' title='BioShares Biotechnology Products ETF'>BBP</a> <font color='red'>-2.7%</font>)(<a href='https://seekingalpha.com/symbol/AMGN' title='Amgen Inc.'>AMGN</a> <font color='red'>-1.3%</font>)(<a href='https://seekingalpha.com/symbol/BIIB' title='Biogen Inc.'>BIIB</a> <font color='red'>-1.9%</font>)(<a href='https://seekingalpha.com/symbol/GILD' title='Gilead Sciences, Inc.'>GILD</a> <font color='red'>-1.4%</font>)(<a href='https://seekingalpha.com/symbol/VRTX' title='Vertex Pharmaceuticals Incorporated'>VRTX</a> <font color='red'>-1.8%</font>)(<a href='https://seekingalpha.com/symbol/CELG' title='Celgene Corporation'>CELG</a> <font color='green'>+0.6%)</font>(<a href='https://seekingalpha.com/symbol/GLPG' title='Galapagos'>GLPG</a> <font color='red'>-1%</font>)(<a href='https://seekingalpha.com/symbol/ALNY' title='Alnylam Pharmaceuticals, Inc.'>ALNY</a> <font color='red'>-3.4%</font>)(<a href='https://seekingalpha.com/symbol/XON' title='Intrexon Corp'>XON</a> <font color='red'>-1.6%</font>)(<a href='https://seekingalpha.com/symbol/EDIT' title='Editas Medicine'>EDIT</a> <font color='red'>-5.3%</font>)(<a href='https://seekingalpha.com/symbol/NTLA' title='Intellia Therapeutics'>NTLA</a> <font color='red'>-3.7%</font>)(<a href='https://seekingalpha.com/symbol/CRSP' title='CRISPR Therapeutics'>CRSP</a> <font color='red'>-11.8%</font>)(<a href='https://seekingalpha.com/symbol/BLUE' title='bluebird bio, Inc.'>BLUE</a> <font color='red'>-3%</font>)(<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a> <font color='red'>-0.2%</font>)(<a href='https://seekingalpha.com/symbol/SGEN' title='Seattle Genetics, Inc.'>SGEN</a> <font color='red'>-2.7%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329914\" data-linked=\"Biotechs continue selloff, XBI down almost 3%\" data-tweet=\"$AMGN $XBI $IBB - Biotechs continue selloff, XBI down almost 3% https://seekingalpha.com/news/3329914-biotechs-continue-selloff-xbi-down-almost-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3329914-biotechs-continue-selloff-xbi-down-almost-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>51&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329913\" data-ts=\"1518193413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRBT\" target=\"_blank\">IRBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329913-sidoti-points-to-upside-potential-on-irobot\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sidoti points to the upside potential on iRobot</a></h4><ul> <li>Sidoti steps into the mix on iRobot (<a href='https://seekingalpha.com/symbol/IRBT' title='iRobot Corporation'>IRBT</a> <font color='red'>-4.3%</font>) with an upgrade to Buy after watching the stock peel more than 35% this week.</li> <li>The analyst team sees downside risk limited at iRobot's current trading level.</li> <li>The investment firm's price target of $90 reps +60% upside potential.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3329913\" data-linked=\"Sidoti points to the upside potential on iRobot\" data-tweet=\"$IRBT - Sidoti points to the upside potential on iRobot https://seekingalpha.com/news/3329913-sidoti-points-to-upside-potential-on-irobot?source=tweet\" data-url=\"https://seekingalpha.com/news/3329913-sidoti-points-to-upside-potential-on-irobot\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329903\" data-ts=\"1518192184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WAIR\" target=\"_blank\">WAIR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329903-wesco-aircraft-flies-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Wesco Aircraft flies after earnings</a></h4><ul> <li>Wesco Aircraft (<a href='https://seekingalpha.com/symbol/WAIR' title='Wesco Aircraft Holdings'>WAIR</a> <font color='green'>+25.2%</font>) soars after FQ1 revenue arrives $16M above consensus and the company records a penny beat on the bottom line.</li> <li>Looking ahead, Wesco expects  a low single-digit percent increase in sales for the full fiscal year and a low double-digit percent increase in adjusted EBITDA.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329628-wesco-aircraft-beats-0_02-beats-revenue\" target=\"_blank\">Wesco Aircraft beats by $0.02, beats on revenue</a> (Feb. 8)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3329903\" data-linked=\"Wesco Aircraft flies after earnings\" data-tweet=\"$WAIR - Wesco Aircraft flies after earnings https://seekingalpha.com/news/3329903-wesco-aircraft-flies-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3329903-wesco-aircraft-flies-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:03 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329876\" data-ts=\"1518192089\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AQXP\" target=\"_blank\">AQXP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329876-healthcare-top-5-gainers-losers-of-11-00-2-9-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/9/2018)</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/AQXP' title='Aquinox Pharmaceuticals, Inc.'>AQXP</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/XENE' title='Xenon Pharmaceuticals'>XENE</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/VIVE' title='Viveve Medical, Inc.'>VIVE</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/AVGR' title='Avinger'>AVGR</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-21%</font>. <a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/ONVO' title='Organovo Holdings, Inc.'>ONVO</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/CTXR' title='Citius Pharmaceuticals Inc.'>CTXR</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/TYHT' title='Shineco, Inc.'>TYHT</a> <font color='red'>-16%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329876\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/9/2018)\" data-tweet=\"$AQXP $NLTX $CTIC - Healthcare - Top 5 Gainers / Losers as of 11:00 am (2/9/2018) https://seekingalpha.com/news/3329876-healthcare-top-5-gainers-losers-of-11-00-2-9-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3329876-healthcare-top-5-gainers-losers-of-11-00-2-9-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329898\" data-ts=\"1518191486\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329898-stocks-reverse-big-early-gains-turn-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stocks reverse big early gains, turn lower</a></h4><ul><li>Massive volatility reigns once again, with&nbsp;<font color='green'>1%+ early gains</font>&nbsp;for the averages reversing into the red a bit more than an hour into the session. Things might go green before we hit the \"send\" button, but at the moment the S&amp;P 500 and Nasdaq are&nbsp;<font color='red'>down 0.3%</font>&nbsp;and the Dow&nbsp;<font color='red'>0.8%</font>.</li><li>Oil continues to tumble,&nbsp;<font color='red'>down another 2%</font>&nbsp;and below $60 per barrel.</li><li>The 10-year Treasury yield is holding steady at 2.83%.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329898\" data-linked=\"Stocks reverse big early gains, turn lower\" data-tweet=\"Stocks reverse big early gains, turn lower https://seekingalpha.com/news/3329898-stocks-reverse-big-early-gains-turn-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3329898-stocks-reverse-big-early-gains-turn-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>23&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329897\" data-ts=\"1518191295\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ESS\" target=\"_blank\">ESS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329897-apartment-reits-in-green-bears-cut-bets\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Apartment REITs in the green as bears cut bets</a></h4><ul><li>The sector is seeing three upgrades from underperform (or the equivalent) this morning, with Mizuho boosting Essex Property (<a href='https://seekingalpha.com/symbol/ESS' title='Essex Property Trust, Inc.'>ESS</a> <font color='green'>+2.6%</font>), and Zelman, AvalonBay (<a href='https://seekingalpha.com/symbol/AVB' title='AvalonBay Communities, Inc.'>AVB</a> <font color='green'>+1.1%</font>) and Aimco (<a href='https://seekingalpha.com/symbol/AIV' title='Apartment Investment & Management Company'>AIV</a> <font color='green'>+1.5%</font>).</li><li>Mizuho takes note of Essex's upbeat guidance as easing Street fears.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329098-essex-property-sees-4_5-percent-ffo-growth-2018\" target=\"_blank\">Essex Property sees about 4.5% FFO growth in 2018</a> (Feb. 7)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3327039-avalonbay-meets-q4-estimates-sees-3_6-percent-ffo-growth-2018\" target=\"_blank\">AvalonBay meets Q4 estimates, sees 3.6% FFO growth in 2018</a> (Jan. 31)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329897\" data-linked=\"Apartment REITs in the green as bears cut bets\" data-tweet=\"$ESS $ESS $AVB - Apartment REITs in the green as bears cut bets https://seekingalpha.com/news/3329897-apartment-reits-in-green-bears-cut-bets?source=tweet\" data-url=\"https://seekingalpha.com/news/3329897-apartment-reits-in-green-bears-cut-bets\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329896\" data-ts=\"1518191136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WEB\" target=\"_blank\">WEB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329896-web-comminus-16_7-after-q4-beats-downside-guidance-analyst-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Web.com -16.7% after Q4 beats, downside guidance, analyst downgrade</a></h4><ul><li>        Web.com (NASDAQ:<a href='https://seekingalpha.com/symbol/WEB' title='Web.com Group, Inc'>WEB</a>) reports Q4 results with EPS and revenue that beat estimates but downside guidance.</li><li>               Q1 guidance: Revenue, $184M to $187M (consensus: $192.10M); adjusted EBITDA, $40.5M to $42.5M.&nbsp;</li><li>               FY18 guidance: $755M to $770M ($783.43M); adjusted EBITDA, $192M to $197M.&nbsp;</li><li>               <a href=\"https://seekingalpha.com/pr/17070309-web-com-reports-fourth-quarter-full-year-2017-financial-results\" target=\"_blank\">Earnings release</a>&nbsp;</li><li>               The company also announced that CFO Kevin Carney will retire, effective June 30.&nbsp;</li><li>               Analyst action: BWS Financial downgrades Web.com from Buy to Hold with a price target of $19.&nbsp;</li><li>               Firm says Web.com&rsquo;s adjustment period is taking much longer than initial estimates.&nbsp;</li><li>               Subscriber loss accelerated in Q4. The company expects more losses in Q1 as Web.com is no longer investing in low margin retail products.&nbsp;</li><li>               Firm fears further underperformance in store with management dealing with debt maturity on top of the competitive pressures of the business.&nbsp;</li><li>               Source: Briefing.com.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Web.com shares are&nbsp;<font color='red'>down 16.7%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329627-web-com-beats-0_41-beats-revenue\" target=\"_blank\">Web.com beats by $0.41, beats on revenue</a> (Feb. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329896\" data-linked=\"Web.com -16.7% after Q4 beats, downside guidance, analyst downgrade\" data-tweet=\"$WEB - Web.com -16.7% after Q4 beats, downside guidance, analyst downgrade https://seekingalpha.com/news/3329896-web-comminus-16_7-after-q4-beats-downside-guidance-analyst-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3329896-web-comminus-16_7-after-q4-beats-downside-guidance-analyst-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:45 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329895\" data-ts=\"1518191084\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OSK\" target=\"_blank\">OSK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329895-oshkosh-lively-after-evercore-nod\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oshkosh lively after Evercore nod</a></h4><ul> <li>Vehicle maker Oshkosh (<a href='https://seekingalpha.com/symbol/OSK' title='Oshkosh Corporation'>OSK</a> <font color='green'>+2%</font>) is on the move after a timely <a href=\"https://twitter.com/AnalystWire/status/961917051936886785\" target=\"_blank\">upgrade</a> from Evercore ISI.</li> <li>The investment firm moves to an Outperform rating from Market Perform.</li> <li>Evercore's price target of $100 reps 17% upside potential for shares.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3329895\" data-linked=\"Oshkosh lively after Evercore nod\" data-tweet=\"$OSK - Oshkosh lively after Evercore nod https://seekingalpha.com/news/3329895-oshkosh-lively-after-evercore-nod?source=tweet\" data-url=\"https://seekingalpha.com/news/3329895-oshkosh-lively-after-evercore-nod\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329894\" data-ts=\"1518191073\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBOE\" target=\"_blank\">CBOE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329894-cboe-slumps-another-12-after-earnings-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cboe slumps another 12% after earnings miss</a></h4><ul><li>It's been a rough few days for Cboe Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/CBOE' title='CBOE Holdings'>CBOE</a>), first with the VIX blowup leading some to question the future of one of the exchange's big rainmakers, and now this morning's Q4 earnings miss.</li><li>Today's&nbsp;<font color='red'>11.8 decline</font>&nbsp;brings this month's<font color='red'> tumble to more than 25%</font>.</li><li>Q4 results obviously include none of February's tribulations, but remind of what a powerhouse VIX is, with futures average daily trading volume in 2017 of 294K, up 23% Y/Y.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329811-cboe-holdings-misses-0_01-misses-revenue\" target=\"_blank\">CBOE Holdings misses by $0.01, misses on revenue</a> (Feb. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329894\" data-linked=\"Cboe slumps another 12% after earnings miss\" data-tweet=\"$CBOE - Cboe slumps another 12% after earnings miss https://seekingalpha.com/news/3329894-cboe-slumps-another-12-after-earnings-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3329894-cboe-slumps-another-12-after-earnings-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329893\" data-ts=\"1518190826\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JNPR\" target=\"_blank\">JNPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329893-doj-closes-fcpa-probe-of-juniper-networks-no-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">DOJ closes FCPA probe of Juniper Networks with no action</a></h4><ul>   <li>In an <a href=\"https://seekingalpha.com/filing/3870826\" target=\"_blank\">SEC filing</a>, Juniper Networks (<a href=\"http://seekingalpha.com/symbol/JNPR\" target=\"_blank\">JNPR</a> <font color='green'>+1.6%</font>) says it's heard from the Justice Dept. that its investigation into possible violations of the Foreign Corrupt Practices Act has closed with no action against Juniper.</li>    <li>The DOJ acknowledged Juniper's cooperation in the matter, the company says, and it adds that an SEC FCPA probe hasn't yet been resolved.</li>    <li>Meanwhile, Juniper says its chief customer officer, Vincent Molinaro, will step down. He'll serve as interim CCO until a successor is in place.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329893\" data-linked=\"DOJ closes FCPA probe of Juniper Networks with no action\" data-tweet=\"$JNPR - DOJ closes FCPA probe of Juniper Networks with no action https://seekingalpha.com/news/3329893-doj-closes-fcpa-probe-of-juniper-networks-no-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3329893-doj-closes-fcpa-probe-of-juniper-networks-no-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329891\" data-ts=\"1518190572\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIOA\" target=\"_blank\">BIOA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329891-bioamber-to-sell-over-46m-units-in-direct-offering-40-discount-public-offering-canceled\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BioAmber to sell over 46M units in direct offering at 40% discount, public offering canceled; shares down 7%</a></h4><ul><li>BioAmber (<a href='https://seekingalpha.com/symbol/BIOA' title='BioAmber'>OTC:BIOA</a>) inks <a href=\"https://seekingalpha.com/pr/17070895-bioamber-inc-announces-registered-direct-offering-termination-underwriting-agreement\" target=\"_blank\">agreements </a>with institutional investors for the aggregate sale of 46.67M Series A units (or equivalent Series B units) at a price of $0.15 per unit ($0.149/Series B unit to pay for the pre-funded warrant), 40% below its planned public offering price of $0.25 per unit.</li><li>The company has terminated its previously announced public offering.</li><li>Shares are off&nbsp;<font color='red'>7%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3328325-bioamber-prices-equity-offering\" target=\"_blank\">BioAmber prices equity offering</a> (Feb. 6)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329891\" data-linked=\"BioAmber to sell over 46M units in direct offering at 40% discount, public offering canceled; shares down 7%\" data-tweet=\"$BIOA - BioAmber to sell over 46M units in direct offering at 40% discount, public offering canceled; shares down 7% https://seekingalpha.com/news/3329891-bioamber-to-sell-over-46m-units-in-direct-offering-40-discount-public-offering-canceled?source=tweet\" data-url=\"https://seekingalpha.com/news/3329891-bioamber-to-sell-over-46m-units-in-direct-offering-40-discount-public-offering-canceled\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329886\" data-ts=\"1518189719\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTCH\" target=\"_blank\">MTCH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329886-aegis-capital-raises-match-group-target-to-25-upside\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aegis Capital raises Match Group target to 25% upside</a></h4><ul><li>        Aegis Capital raises its Match Group (NASDAQ:<a href='https://seekingalpha.com/symbol/MTCH' title='Match Group, Inc.'>MTCH</a>) price target from $32 to $42, a 25% upside on yesterday&rsquo;s close.</li><li>               Firm thinks the new guidance has a high level of built-in conservatism due to cautiousness about new Tinder monetization products launching in Q3.&nbsp;</li><li>               Aegis says Match management has executed strongly in the past year and that momentum should continue, particularly around Tinder subscriber growth and margin expansion.&nbsp;</li><li>               Source: Briefing.com.&nbsp;</li><li>               Match Group shares are&nbsp;<font color='green'>up 4.1%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3328688-match-group-reports-q4-beat-upside-q1-guidance\" target=\"_blank\">Match Group reports Q4 beat, upside Q1 guidance</a> (Feb. 6)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3328958-match-earnings-call-plans-2h-deceleration-mentions-tech-patent\" target=\"_blank\">Match earnings call: Plans for 2H deceleration, mentions tech patent</a> (Feb. 7)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329523-barclays-raises-match-group-price-target-earnings\" target=\"_blank\">Barclays raises its Match Group price target after earnings</a> (Feb. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329886\" data-linked=\"Aegis Capital raises Match Group target to 25% upside\" data-tweet=\"$MTCH - Aegis Capital raises Match Group target to 25% upside https://seekingalpha.com/news/3329886-aegis-capital-raises-match-group-target-to-25-upside?source=tweet\" data-url=\"https://seekingalpha.com/news/3329886-aegis-capital-raises-match-group-target-to-25-upside\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329883\" data-ts=\"1518189576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MPAA\" target=\"_blank\">MPAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329883-post-earnings-slide-for-motorcar-parts-of-america\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings slide for Motorcar Parts of America</a></h4><ul> <li>Motorcar Parts of America (<a href='https://seekingalpha.com/symbol/MPAA' title='Motorcar Parts of America, Inc.'>MPAA</a> <font color='red'>-11.9%</font>) slumps after missing Q4 estimates by a wide margin.</li> <li>Gross profit fell to 27.9% of sales vs. 30.1% a year ago, due to customer allowances related to new business, higher returns, lower overhead absorption and product mix.</li> <li>\"We were disappointed in our results for the quarter, especially since we continued to gain market share across all of our product lines.  While we incurred additional expenses related to new business wins, we did not realize the full benefit of the associated revenues during the quarter,\" says CEO Selwyn Joffe.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329825-motorcar-parts-america-misses-0_15-misses-revenue\" target=\"_blank\">Motorcar Parts of America misses by $0.15, misses on revenue</a> (Feb. 9)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3329883\" data-linked=\"Post-earnings slide for Motorcar Parts of America\" data-tweet=\"$MPAA - Post-earnings slide for Motorcar Parts of America https://seekingalpha.com/news/3329883-post-earnings-slide-for-motorcar-parts-of-america?source=tweet\" data-url=\"https://seekingalpha.com/news/3329883-post-earnings-slide-for-motorcar-parts-of-america\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329882\" data-ts=\"1518189446\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TCEHY\" target=\"_blank\">TCEHY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329882-tencent-netease-music-platforms-in-licensing-cooperation-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tencent, NetEase music platforms in licensing cooperation deal</a></h4><ul>   <li>In a key deal between burgeoning music leaders in China, Tencent Music (<a href=\"http://seekingalpha.com/symbol/TCEHY\" target=\"_blank\">TCEHY</a> <font color='green'>+2%</font>) and NetEase Cloud Music (<a href=\"http://seekingalpha.com/symbol/NTES\" target=\"_blank\">NTES</a> <font color='green'>+2%</font>) have come together to ease licensing.</li>    <li>The two will exchange more than 99% of their exclusive content and work together in the long term on music rights as well as licensing for other streaming platforms, Bloomberg notes, pointing to a statement from the country's National Copyright Administration.</li>    <li>The move could be a boon for the much smaller NetEase music operation against a Tencent music unit that may seek to list as a public entity this year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329882\" data-linked=\"Tencent, NetEase music platforms in licensing cooperation deal\" data-tweet=\"$TCEHY $TCEHY $NTES - Tencent, NetEase music platforms in licensing cooperation deal https://seekingalpha.com/news/3329882-tencent-netease-music-platforms-in-licensing-cooperation-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3329882-tencent-netease-music-platforms-in-licensing-cooperation-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329881\" data-ts=\"1518189179\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329881-analysts-raise-nvidia-price-targets-after-earnings\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts raise Nvidia price targets after earnings</a></h4><ul><li>        B. Riley retains a Buy rating and raises its Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) price target by $20 to $290, a 33% upside on yesterday&rsquo;s closing price. &nbsp;</li><li>        Firm believes positives again strongly outweigh the negatives after yesterday&rsquo;s earnings report and upside potential could persist.</li><li>               Mizuho Securities raises its target from $240 to $265 (22% upside).&nbsp;</li><li>               Firm says Nvidia continues to see Automotive wins with new partners and the Drive platform now in use by more than 320 companies and researchers.&nbsp;</li><li>               Other adjustments: SunTrust to Street-high $305 (was: $253), BofAML to $300 (was: $274), Wells Fargo to $100 (was: $87), and Deutsche Bank to $230 (was: $205).&nbsp;</li><li>               Source: Briefing.com. &nbsp;&nbsp;</li><li>               Nvidia shares are&nbsp;<font color='green'>up 5.6%</font>.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329677-nvidia-plus-11_5-percent-34-percent-revenue-growth-upside-guidance-gaming-data-demand\" target=\"_blank\">Nvidia +11.5% on 34% revenue growth, upside guidance, gaming and data demand</a> (Feb. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329881\" data-linked=\"Analysts raise Nvidia price targets after earnings\" data-tweet=\"$NVDA - Analysts raise Nvidia price targets after earnings https://seekingalpha.com/news/3329881-analysts-raise-nvidia-price-targets-after-earnings?source=tweet\" data-url=\"https://seekingalpha.com/news/3329881-analysts-raise-nvidia-price-targets-after-earnings\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>87&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329878\" data-ts=\"1518188641\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ERIC\" target=\"_blank\">ERIC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329878-ericsson-up-amid-reports-of-deal-talks-ezentis\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ericsson up amid reports of deal talks with Ezentis</a></h4><ul>   <li>Ericsson (<a href=\"http://seekingalpha.com/symbol/ERIC\" target=\"_blank\">ERIC</a> <font color='green'>+2.9%</font>) is higher this morning alongside chatter of a possible transaction with Spanish business group Ezentis.</li>    <li>Bloomberg notes comments in a Spanish regulatory filing that says Ezentis is in talks over a possible acquisition of assets or sales from Ericsson.</li>    <li>There's no decision or agreement on any transaction so far, Ezentis says.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329878\" data-linked=\"Ericsson up amid reports of deal talks with Ezentis\" data-tweet=\"$ERIC - Ericsson up amid reports of deal talks with Ezentis https://seekingalpha.com/news/3329878-ericsson-up-amid-reports-of-deal-talks-ezentis?source=tweet\" data-url=\"https://seekingalpha.com/news/3329878-ericsson-up-amid-reports-of-deal-talks-ezentis\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329877\" data-ts=\"1518188526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEVA\" target=\"_blank\">TEVA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329877-teva-gets-street-low-price-target-from-piper-shares-down-2_6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Teva gets a Street-low price target from Piper; shares down 2.6%</a></h4><ul><li><a href=\"https://twitter.com/thenotablecalls\" target=\"_blank\">via Notable Calls</a></li><li>\"We do not believe that Teva (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) is investable,\" says Piper Jaffray, in a note titled \"The Case For Further Value Destruction.\" The eventual addition of Copaxone generics and a crushing debt burden create a perfect storm of challenges, says the team.</li><li>Piper downgrades to Underweight, with a Street-low price target of $11 suggesting&nbsp;<font color='red'>40% downside</font>&nbsp;from yesterday's close.</li><li>Shares are&nbsp;<font color='red'>down 2.6%</font>&nbsp;to $18.15.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329465-teva-expects-complete-half-workforce-reduction-next-quarter\" target=\"_blank\">Teva expects to complete half of workforce reduction by next quarter</a> (Feb. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329877\" data-linked=\"Teva gets a Street-low price target from Piper; shares down 2.6%\" data-tweet=\"$TEVA - Teva gets a Street-low price target from Piper; shares down 2.6% https://seekingalpha.com/news/3329877-teva-gets-street-low-price-target-from-piper-shares-down-2_6?source=tweet\" data-url=\"https://seekingalpha.com/news/3329877-teva-gets-street-low-price-target-from-piper-shares-down-2_6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>46&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329871\" data-ts=\"1518187930\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYX\" target=\"_blank\">PYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329871-alliance-one-skyrockets-after-announcing-transformation-plans\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alliance One skyrockets after announcing transformation plans</a></h4><ul> <li>Alliance One International (AOI) is <font color='green'>up 26%</font> on a post-earnings rip tied to the company's \"transformational\" plan to expand into the e-liquids, industrial hemp and cannabis markets.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3329662-alliance-one-reports-q3-results\" target=\"_blank\">Alliance One reports Q3 results</a> (Feb. 8)</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3329871\" data-linked=\"Alliance One skyrockets after announcing transformation plans\" data-tweet=\"$PYX - Alliance One skyrockets after announcing transformation plans https://seekingalpha.com/news/3329871-alliance-one-skyrockets-after-announcing-transformation-plans?source=tweet\" data-url=\"https://seekingalpha.com/news/3329871-alliance-one-skyrockets-after-announcing-transformation-plans\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329868\" data-ts=\"1518187228\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QCOM\" target=\"_blank\">QCOM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329868-qualcomm-lose-two-billion-dollar-customers-in-broadcom-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Qualcomm could lose two billion-dollar customers in Broadcom deal</a></h4><ul><li>        Qualcomm (NASDAQ:<a href='https://seekingalpha.com/symbol/QCOM' title='Qualcomm Inc.'>QCOM</a>) <a href=\"https://www.sec.gov/Archives/edgar/data/804328/000110465918007720/a17-28583_35defa14a.htm\" target=\"_blank\">says</a> it could lose two major customers if the revised Broadcom (NASDAQ:<a href='https://seekingalpha.com/symbol/AVGO' title='Broadcom Limited'>AVGO</a>) deal goes forward.</li><li>               Key quote: \"Two customers providing Qualcomm chipset revenues in excess of $1 billion each per year have stated that they are likely to move designs away from Qualcomm in the event that this transaction moves forward. This is due to their lack of confidence in Broadcom&rsquo;s ability to continue to lead in technology.&rdquo;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329591-qualcomm-board-unanimously-rejects-revised-broadcom-offer\" target=\"_blank\">Qualcomm board unanimously rejects revised Broadcom offer</a> (Feb. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329868\" data-linked=\"Qualcomm could lose two billion-dollar customers in Broadcom deal\" data-tweet=\"$QCOM $QCOM $AVGO - Qualcomm could lose two billion-dollar customers in Broadcom deal https://seekingalpha.com/news/3329868-qualcomm-lose-two-billion-dollar-customers-in-broadcom-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3329868-qualcomm-lose-two-billion-dollar-customers-in-broadcom-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>94&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329866\" data-ts=\"1518187052\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LNG\" target=\"_blank\">LNG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329866-cheniere-energy-inks-long-term-deals-to-sell-lng-to-china\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cheniere Energy inks long-term deals to sell LNG to China</a></h4><ul>     <li>Cheniere Energy (<a href='https://seekingalpha.com/symbol/LNG' title='Cheniere Energy, Inc'>LNG</a> <font color='green'>+3.6%</font>) says China National Petroleum (<a href='https://seekingalpha.com/symbol/PTR' title='PetroChina Company Limited'>PTR</a> <font color='green'>+0.6%</font>) agrees to purchase 1.2M metric tons/year of liquefied natural gas, with part of the supply beginning in 2018 and the balance starting in 2023.</li>     <li>The term of each agreement continues through 2043, with the purchase price to be indexed to the Henry Hub price plus a fixed component.</li>     <li>The agreements follow an MoU signed in November, and Cheniere expects them to support the development of Corpus Christi Train 3, \"and we are now focused on completing the remaining necessary steps to reach a final investment decision later this year.&rdquo;</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329866\" data-linked=\"Cheniere Energy inks long-term deals to sell LNG to China\" data-tweet=\"$LNG $LNG $PTR - Cheniere Energy inks long-term deals to sell LNG to China https://seekingalpha.com/news/3329866-cheniere-energy-inks-long-term-deals-to-sell-lng-to-china?source=tweet\" data-url=\"https://seekingalpha.com/news/3329866-cheniere-energy-inks-long-term-deals-to-sell-lng-to-china\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329861\" data-ts=\"1518186253\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LGF.A\" target=\"_blank\">LGF.A</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329861-lions-gate-lower-analysts-trim-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lions Gate lower as analysts trim outlook</a></h4><ul>   <li>Lions Gate Entertainment is sharply lower in some light premarket trading -- <a href='https://seekingalpha.com/symbol/LGF.A' title='Lions Gate Entertainment Corp.'>LGF.A</a> <font color='red'>-15%</font>, <a href='https://seekingalpha.com/symbol/LGF.B' title='Lions Gate Entertainment Corp.'>LGF.B</a> <font color='red'>-11.2%</font> -- after analysts react to <a href=\"https://seekingalpha.com/news/3329724-lions-gate-late-trade-despite-q3-revenue-beat\" target=\"_blank\">Q3 earnings</a> with downgrades and lower targets.</li>    <li>While the company beat expectations with Q3 revenues, SunTrust Robinson Humphrey sees a lower outlook in downgrading the stock to Hold from Buy.</li>    <li>KeyBanc is also cutting the stock to Sector Weight from Overweight. Meanwhile, Piper Jaffray has reduced its price target (to $35) and B. Riley cut its target as well, to $30.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329861\" data-linked=\"Lions Gate lower as analysts trim outlook\" data-tweet=\"$LGF.A $LGF.A $LGF.B - Lions Gate lower as analysts trim outlook https://seekingalpha.com/news/3329861-lions-gate-lower-analysts-trim-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3329861-lions-gate-lower-analysts-trim-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329860\" data-ts=\"1518186075\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PYX\" target=\"_blank\">PYX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329860-premarket-gainers-of-9-05-02-09-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am (02/09/2018)</a></h4><ul>     <li>AOI <font color='green'>+48%</font>&nbsp;on Q3 <a href=\"https://seekingalpha.com/news/3329662-alliance-one-reports-q3-results\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/INPX' title='Inpixon'>INPX</a> <font color='green'>+15%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/ROX' title='Castle Brands Inc'>ROX</a> <font color='green'>+15%</font>&nbsp;on Q3&nbsp;<a href=\"https://seekingalpha.com/news/3329713-castle-brands-reports-q3-results\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/PIRS' title='Pieris Pharmaceuticals, Inc.'>PIRS</a> <font color='green'>+13%&nbsp;</font>as Seattle Genetics teams up in immuno-oncology.</li>     <li><a href='https://seekingalpha.com/symbol/FEYE' title='FireEye, Inc.'>FEYE</a>&nbsp;<font color='green'>+12%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3329803-susquehanna-upgrades-fireeye\" target=\"_blank\">upgrade</a>.</li>     <li><a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a> <font color='green'>+9%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3329625-nvidia-beats-0_56-beats-revenue\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/PRPO' title='Precipio, Inc.'>PRPO</a> <font color='green'>+7%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/pr/17070871-precipio-announces-q4-2017-revenue-350-percent-previous-quarter\" target=\"_blank\">revenue</a></li>     <li><a href='https://seekingalpha.com/symbol/CTIC' title='CTI BioPharma Corp.'>CTIC</a> <font color='green'>+7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3329801-cti-biopharma-prices-stock-offering-3_00\" target=\"_blank\">pricing</a> of common stock offering.</li>     <li><a href='https://seekingalpha.com/symbol/XIN' title='Xinyuan Real Estate Co., Ltd.'>XIN</a> <font color='green'>+5%</font>&nbsp;on Q4 <a href=\"https://seekingalpha.com/news/3329754-xinyuan-real-estate-reports-q4-results\" target=\"_blank\">result</a>.</li>     <li><a href='https://seekingalpha.com/symbol/HMY' title='Harmony Gold Mining Company Limited'>HMY</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329860\" data-linked=\"Premarket Gainers as of 9:05 am (02/09/2018)\" data-tweet=\"$PYX $PYX $INPX - Premarket Gainers as of 9:05 am (02/09/2018) https://seekingalpha.com/news/3329860-premarket-gainers-of-9-05-02-09-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3329860-premarket-gainers-of-9-05-02-09-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:21 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329857\" data-ts=\"1518185526\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PACB\" target=\"_blank\">PACB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329857-pacific-bio-down-2-premarket-on-itc-patent-ruling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pacific Bio down 2% premarket on ITC patent ruling</a></h4><ul><li>Pacific Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/PACB' title='Pacific Biosciences of California'>PACB</a>) slips&nbsp;<font color='red'>2%</font>&nbsp;premarket on the heels of its <a href=\"https://seekingalpha.com/pr/17070579-pacific-biosciences-announces-outcome-first-phase-patent-litigation-oxford-nanopore\" target=\"_blank\">announcement </a>that the U.S. International Trade Commission &#40;ITC&#41; has terminated its investigation into whether Oxford Nanopore's MinION and PromethION devices and their consumables, reagents and software infringe on two U.S. patents (Nos. 9,404,146 and 9,542,527) owned by Pacific. The company believes Oxford's 2D method infringes on the two.</li><li>The ITC interpreted the term \"single-molecule sequencing\" as limited to sequencing-by-synthesis approaches, determining that Oxford's sequencing approach is not \"single-molecule sequencing.\"</li><li>CEO Dr. Michael Hunkapiller says, &ldquo;We disagree with the present determination of non-infringement in this lawsuit, and note that the ITC&rsquo;s construction of the term &lsquo;single-molecule sequencing&rsquo; is inconsistent with both the commonly understood meaning of that term as well as relevant U.S. Supreme Court and Federal Circuit precedent. We continue to stand firm in our resolve to protect our investment and leadership position in the field we have created, and we look forward to the next phases of our litigation against Oxford Nanopore in the&nbsp;U.S.&nbsp;and Europe.&rdquo;</li></ul><div class=\"tiny-share-widget\" data-id=\"3329857\" data-linked=\"Pacific Bio down 2% premarket on ITC patent ruling\" data-tweet=\"$PACB - Pacific Bio down 2% premarket on ITC patent ruling https://seekingalpha.com/news/3329857-pacific-bio-down-2-premarket-on-itc-patent-ruling?source=tweet\" data-url=\"https://seekingalpha.com/news/3329857-pacific-bio-down-2-premarket-on-itc-patent-ruling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329858\" data-ts=\"1518185523\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329858-premarket-losers-of-9-05-2-9-2018\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am (2/9/2018)</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>&nbsp;<font color='red'>-32%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3329845-tandem-diabetes-prices-stock-offering-2_00-shares-26-percent-premarket\" target=\"_blank\">pricing</a> stock offering at $2.00</li><li><a href='https://seekingalpha.com/symbol/MGEN' title='Miragen Therapeutics, Inc.'>MGEN</a>&nbsp;<font color='red'>-19%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3329769-miragen-prices-stock-offering-5_50\" target=\"_blank\">pricing</a> stock offering at $5.50.</li><li><a href='https://seekingalpha.com/symbol/EXPE' title='Expedia, Inc.'>EXPE</a>&nbsp;<font color='red'>-16%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3329574-expedia-misses-0_31-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li><li><a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a>&nbsp;<font color='red'>-8%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3329842-phase-1-2-data-catalyst-bios-hemophilia-b-candidate-underwhelms-investors-shares-12-percent\" target=\"_blank\">announcing</a> top-line data from Phase 1/2 study of subcutaneous CB 2679d/ISU304.</li><li><a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>&nbsp;<font color='red'>-8%</font>&nbsp;on&nbsp;<a href=\"https://seekingalpha.com/news/3329800-bio-path-executes-1-10-reverse-split-common-stock\" target=\"_blank\">executing</a> 1:10 reverse split of common stock.</li><li><a href='https://seekingalpha.com/symbol/CBL' title='CBL & Associates Properties, Inc.'>CBL</a>&nbsp;<font color='red'>-7%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3329611-cbl-and-associates-properties-misses-0_01-misses-revenue\" target=\"_blank\">Q4 earnings</a>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3329858\" data-linked=\"Premarket Losers as of 9:05 am (2/9/2018)\" data-tweet=\"$TNDM $TNDM $MGEN - Premarket Losers as of 9:05 am (2/9/2018) https://seekingalpha.com/news/3329858-premarket-losers-of-9-05-2-9-2018?source=tweet\" data-url=\"https://seekingalpha.com/news/3329858-premarket-losers-of-9-05-2-9-2018\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329855\" data-ts=\"1518185157\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GME\" target=\"_blank\">GME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329855-gamestop-continues-management-shuffle\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GameStop continues management shuffle</a></h4><ul>     <li>GameStop (NYSE:<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a>) terminated the employment of COO Tony Bartel and Executive VP of Strategic Business and Brand Development Michael Hogan, according to a SEC filing.</li><li>The company says the terminations were without cause.</li><li>Earlier this week, GameStop promoted Michael Mauler to be its new CEO.</li><li>Shares of GameStop are&nbsp;<font color='green'>up 1.07%</font>&nbsp;premarket to $16.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329855\" data-linked=\"GameStop continues management shuffle\" data-tweet=\"$GME - GameStop continues management shuffle https://seekingalpha.com/news/3329855-gamestop-continues-management-shuffle?source=tweet\" data-url=\"https://seekingalpha.com/news/3329855-gamestop-continues-management-shuffle\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329849\" data-ts=\"1518184779\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INTU\" target=\"_blank\">INTU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329849-intuit-adjusts-q2-outlook-due-to-late-tax-season\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Intuit adjusts Q2 outlook due to late tax season</a></h4><ul><li>        Intuit (NASDAQ:<a href='https://seekingalpha.com/symbol/INTU' title='Intuit Inc.'>INTU</a>) <a href=\"https://seekingalpha.com/pr/17070789-intuit-shifts-quarterly-outlook-citing-late-opening-tax-season-raises-full-year-earnings-per\" target=\"_blank\">says</a> Q2 revenue and operating income was lower than expected due to the IRS accepting tax filings six days later than last year.</li><li>               Intuit expects tax revenue to shift to Q3.&nbsp;</li><li>               Updated Q2 guidance: Revenue, $1.16B to $1.17B (was: $1.16M to $1.18M; consensus: $1.15B); EPS, $0.34 to $0.35 (was: $0.31 to $0.34; consensus: $0.31); non-GAAP operating income, $115M to $120M (was: $130M to $140M).&nbsp;</li><li>               FY18 guidance (mostly reaffirmed): Revenue, $5.64B to $5.74B (consensus: $5.71B); non-GAAP operating income, $1.89B to $1.94B; QuickBooks Online subscribers, 3.28M to 3.38M; EPS, $5.30 to $5.40 (was: $4.90 to $5; consensus: $5.16).&nbsp;</li><li>               Tax reform impact: Intuit expects a statutory federal rate of 26.9% for FY18 with the company fully benefitting from the change in FY19.&nbsp;</li><li>               Intuit reports Q2 results on February 22.&nbsp;&nbsp;</li><li>Intuit shares are&nbsp;<font color='red'>down 0.9%</font>&nbsp;premarket.&nbsp; &nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3329849\" data-linked=\"Intuit adjusts Q2 outlook due to late tax season\" data-tweet=\"$INTU - Intuit adjusts Q2 outlook due to late tax season https://seekingalpha.com/news/3329849-intuit-adjusts-q2-outlook-due-to-late-tax-season?source=tweet\" data-url=\"https://seekingalpha.com/news/3329849-intuit-adjusts-q2-outlook-due-to-late-tax-season\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329845\" data-ts=\"1518184338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329845-tandem-diabetes-prices-stock-offering-2_00-shares-down-26-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tandem Diabetes prices stock offering at $2.00; shares down 26% premarket</a></h4><ul><li>Tandem Diabetes Care (NASDAQ:<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>) plummets&nbsp;<font color='red'>26%</font>&nbsp;premarket in response to its <a href=\"https://seekingalpha.com/pr/17070793-tandem-diabetes-care-announces-pricing-60-million-underwritten-public-offering-common-stock\" target=\"_blank\">public offering</a> of 30M shares of common stock at $2.00 per share. Underwriters over-allotment is an additional 4.5M shares. Closing date is February 13.</li><li>Yesterday's close was $2.92.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329845\" data-linked=\"Tandem Diabetes prices stock offering at $2.00; shares down 26% premarket\" data-tweet=\"$TNDM - Tandem Diabetes prices stock offering at $2.00; shares down 26% premarket https://seekingalpha.com/news/3329845-tandem-diabetes-prices-stock-offering-2_00-shares-down-26-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3329845-tandem-diabetes-prices-stock-offering-2_00-shares-down-26-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329843\" data-ts=\"1518184085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329843-jobs-vanish-in-canada-to-start-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jobs vanish in Canada to start the year</a></h4><ul><li>Canada just had its weakest employment print since the depths of the financial crisis, <a href=\"https://www.statcan.gc.ca/daily-quotidien/180209/dq180209a-eng.htm?HPA=1\" target=\"_blank\">losing 88K jobs in January</a>. Expectations had been for a gain of 10K.</li><li>The unemployment rate ticked higher to 5.9%.</li><li>The loonie (NYSEARCA:<a href='https://seekingalpha.com/symbol/FXC' title='CurrencyShares Canadian Dollar Trust ETF'>FXC</a>) knee-jerked lower on the release of the news, but has bounced since, now flat vs. the greenback at $0.7932.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/EWC' title='iShares MSCI Canada ETF'>EWC</a>, <a href='https://seekingalpha.com/symbol/CNDA' title='IQ Canada Small Cap ETF'>CNDA</a>, <a href='https://seekingalpha.com/symbol/EWCS' title='iShares MSCI Canada Small Cap Index ETF'>EWCS</a>, <a href='https://seekingalpha.com/symbol/QCAN' title='SPDR MSCI Canada Quality Mix ETF'>QCAN</a>, <a href='https://seekingalpha.com/symbol/FCAN' title='First Trust Canada AlphaDex ETF'>FCAN</a>, <a href='https://seekingalpha.com/symbol/HEWC' title='iShares Currency Hedged MSCI Canada ETF'>HEWC</a>, <a href='https://seekingalpha.com/symbol/FLCA' title='Franklin FTSE Canada ETF'>FLCA</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3329843\" data-linked=\"Jobs vanish in Canada to start the year\" data-tweet=\"$FXC $EWC $CNDA - Jobs vanish in Canada to start the year https://seekingalpha.com/news/3329843-jobs-vanish-in-canada-to-start-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3329843-jobs-vanish-in-canada-to-start-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329842\" data-ts=\"1518184015\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CBIO\" target=\"_blank\">CBIO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329842-phase-1-2-data-on-catalyst-bios-hemophilia-b-candidate-underwhelms-investors-shares-down-12\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Phase 1/2 data on Catalyst Bio&#39;s hemophilia B candidate underwhelms investors, shares down 12% premarket</a></h4><ul><li>Catalyst Biosciences (NASDAQ:<a href='https://seekingalpha.com/symbol/CBIO' title='Catalyst Biosciences, Inc.'>CBIO</a>) slumps&nbsp;<font color='red'>12%</font>&nbsp;premarket in response to its <a href=\"https://seekingalpha.com/pr/17070713-catalyst-biosciences-announces-positive-top-line-data-phase-1-2-study-subcutaneous-cb-2679d\" target=\"_blank\">announcement </a>of topline data from a Phase 1/2 clinical trial evaluating subcutaneous &#40;SQ&#41;&nbsp;administration of hemophilia B candidate CB 2679d/ISU304. The results were presented at the European Association for Hemophilia and Allied Disorders &#40;EAHAD&#41; Annual Congress in Madrid.</li><li>After six days of SQ dosing in five patients with severe hemophilia B, CB 2679d increased factor IX &#40;FIX&#41;&nbsp;levels to a median of 16% (range: 11.5 - 18%), within the mild hemophilia range (5 - 40%). The observed increase in FIX levels was linear so the company says continued dosing may achieve more significant results.</li><li>The SQ half-life was 63.2 hours, significantly lower than 98.7 hours reported in December.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3317484-catalyst-bio-13-percent-positive-phase-1-2-data-hemophilia-b-candidate\" target=\"_blank\">Catalyst Bio up 13% on positive Phase 1/2 data on hemophilia B candidate</a> (Dec. 11, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329842\" data-linked=\"Phase 1/2 data on Catalyst Bio&#39;s hemophilia B candidate underwhelms investors, shares down 12% premarket\" data-tweet=\"$CBIO - Phase 1/2 data on Catalyst Bio&#39;s hemophilia B candidate underwhelms investors, shares down 12% premarket https://seekingalpha.com/news/3329842-phase-1-2-data-on-catalyst-bios-hemophilia-b-candidate-underwhelms-investors-shares-down-12?source=tweet\" data-url=\"https://seekingalpha.com/news/3329842-phase-1-2-data-on-catalyst-bios-hemophilia-b-candidate-underwhelms-investors-shares-down-12\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329839\" data-ts=\"1518183694\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GLPI\" target=\"_blank\">GLPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329839-union-gaming-positive-on-gaming-and-leisure-properties\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Union Gaming positive on Gaming and Leisure Properties</a></h4><ul> <li>Gaming and Leisure Properties (NASDAQ:<a href='https://seekingalpha.com/symbol/GLPI' title='Gaming and Leisure Properties'>GLPI</a>) is&nbsp;<font color='green'>up 3%</font>&nbsp;in premarket action after the company's Q4 EBITDA came in slightly ahead of estimates on revenue of $241M.</li> <li>Union Gaming analyst John DeCree reiterates a Buy rating on the casino REIT, even though U.S. Treasury yields are marching higher. The \"attractive\" dividend yield on GLPI&nbsp;is still in play, contends DeCree.</li> <li>\"The shares currently trade with a 6.4% LTM dividend yield and a projected 8.2% yield based on our 2019 pro forma dividend per share estimate of $2.72, which is quite compelling in our view,\" he writes.</li>  <li>Union Gaming's price target on GLPI is maintained at $40.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329336-gaming-leisure-properties-misses-revenue\" target=\"_blank\">Gaming and Leisure Properties misses on revenue</a> (Feb. 8)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329839\" data-linked=\"Union Gaming positive on Gaming and Leisure Properties\" data-tweet=\"$GLPI - Union Gaming positive on Gaming and Leisure Properties https://seekingalpha.com/news/3329839-union-gaming-positive-on-gaming-and-leisure-properties?source=tweet\" data-url=\"https://seekingalpha.com/news/3329839-union-gaming-positive-on-gaming-and-leisure-properties\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329837\" data-ts=\"1518183541\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIG\" target=\"_blank\">AIG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329837-aig-turns-higher-after-big-q4-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AIG turns higher after big Q4 miss</a></h4><ul><li>The sell-side is taking the rough headline miss in stride, led by BAML's Jay Cohen, upgrading to Buy from Neutral. His $70 price target suggests&nbsp;<font color='green'>20% upside</font>&nbsp;from yesterday's close.</li><li>Evercore's Thomas Gallagher: \"This is the first quarter in a while where we are seeing some positive signs emerging within the P&amp;C business.\" He rates at Outperform with $72 price target.</li><li>Investors had been worried about a sizable reserve charge, says Wells Fargo's Elyse Greenspan, so should take comfort that there was little movement in Q4.</li><li>The conference call got underway about 40 minutes ago. <a href=\"http://www.aig.com/content/dam/aig/america-canada/us/documents/investor-relations/2018/4q17-conference-call-presentation-final-v2.pdf\" target=\"_blank\">Presentation slides here</a>.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329720-aig-flat-following-q4-results-record-4_2b-full-year-catastrophe-losses\" target=\"_blank\">AIG flat following Q4 results; had record $4.2B full-year catastrophe losses</a> (Feb. 8)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329619-american-international-group-misses-0_18\" target=\"_blank\">American International Group misses by $0.18</a> (Feb. 8)</li><li><a href='https://seekingalpha.com/symbol/AIG' title='American International Group Inc'>AIG</a>&nbsp;<font color='green'>+2%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3329837\" data-linked=\"AIG turns higher after big Q4 miss\" data-tweet=\"$AIG - AIG turns higher after big Q4 miss https://seekingalpha.com/news/3329837-aig-turns-higher-after-big-q4-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3329837-aig-turns-higher-after-big-q4-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329833\" data-ts=\"1518182758\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCJ\" target=\"_blank\">CCJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329833-camecoplus-3-after-q4-earnings-beat-improved-uranium-pricing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cameco +3% after Q4 earnings beat, improved uranium pricing</a></h4><ul>     <li>Cameco (NYSE:<a href='https://seekingalpha.com/symbol/CCJ' title='Cameco Corporation'>CCJ</a>)&nbsp;<font color='green'>+3%</font> premarket after reporting better than expected <a href=\"https://seekingalpha.com/news/3329814-cameco-beats-0_11-beats-revenue\" target=\"_blank\">Q4 earnings</a>, helped by higher prices and the company's <a href=\"https://www.reuters.com/article/us-cameco-results/uranium-miner-cameco-posts-smaller-fourth-quarter-loss-idUSKBN1FT1SL\" target=\"_blank\">efforts to streamline its business</a>.</li>     <li>CCJ says Q4 uranium production volume totaled 6.9M lbs., down 3% Y/Y, but sales volume rose 8% to 12.6M lbs., while the averaged realized price rose 4% Y/Y to US$39.44/lb.; for FY 2017, production volume of 23.8M lbs. was down 12% Y/Y, and sales volume fell 7% to 33.6M lbs., while averaged realized price for the full year fell 12% to $36.13/lb.</li>     <li>However, Q4 revenues fell 8% Y/Y to C$809M, and CCJ forecasts FY 2018 revenues of C$1.8B-C$1.93B vs. C$2.03B analyst consensus; the company also sees full-year sales volume of 32M-33M lbs.</li><li>CCJ also <a href=\"https://seekingalpha.com/pr/17070510-cameco-s-board-appoints-new-chair\" target=\"_blank\">appoints</a> Ian Bruce as chair effective at the company&rsquo;s annual general meeting on May 16; he will succeed Neil McMillan, who is retiring.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329833\" data-linked=\"Cameco +3% after Q4 earnings beat, improved uranium pricing\" data-tweet=\"$CCJ - Cameco +3% after Q4 earnings beat, improved uranium pricing https://seekingalpha.com/news/3329833-camecoplus-3-after-q4-earnings-beat-improved-uranium-pricing?source=tweet\" data-url=\"https://seekingalpha.com/news/3329833-camecoplus-3-after-q4-earnings-beat-improved-uranium-pricing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:25 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329818\" data-ts=\"1518182107\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PULM\" target=\"_blank\">PULM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329818-premarket-analyst-action-healthcare\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket analyst action - healthcare</a></h4><ul><li>Pulmatrix (NASDAQ:<a href='https://seekingalpha.com/symbol/PULM' title='Pulmatrix, Inc.'>PULM</a>) initiated with Buy rating and $5 (228% upside) price target at H.C. Wainwright.</li><li>Aquinox Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/AQXP' title='Aquinox Pharmaceuticals, Inc.'>AQXP</a>) initiated with Buy rating and $26 (94% upside) price target at Guggenheim.</li><li>Aclaris Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/ACRS' title='Aclaris Therapeutics'>ACRS</a>) initiated with Buy rating and $53 (171% upside) price target at Guggenheim.</li><li>Diplomat Pharmacy (NYSE:<a href='https://seekingalpha.com/symbol/DPLO' title='Diplomat Pharmacy'>DPLO</a>) initiated with Buy rating and $35 (47% upside) price target at Lake Street.</li><li>CVS Health (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) downgraded to Buy from Strong Buy at Needham.</li><li>Hologic (NASDAQ:<a href='https://seekingalpha.com/symbol/HOLX' title='Hologic, Inc.'>HOLX</a>) downgraded to Hold with a $42 (8% upside) price target at Stifel.</li><li>Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) downgraded to Underweight at Piper Jaffray. Downgraded to Hold at Gabelli &amp; Co. Upgraded to Sector Perform at RBC Capital Markets. Downgraded to \"BB\" by S&amp;P.</li><li>Regeneron Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/REGN' title='Regeneron Pharmaceuticals, Inc.'>REGN</a>) downgraded to Neutral at BTIG Research. Upgraded to Outperform at Robert W. Baird.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329818\" data-linked=\"Premarket analyst action - healthcare\" data-tweet=\"$PULM $PULM $NLTX - Premarket analyst action - healthcare https://seekingalpha.com/news/3329818-premarket-analyst-action-healthcare?source=tweet\" data-url=\"https://seekingalpha.com/news/3329818-premarket-analyst-action-healthcare\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329831\" data-ts=\"1518182055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TEN\" target=\"_blank\">TEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329831-on-tennecos-q4-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Tenneco&#39;s Q4 beat</a></h4><ul><li>Tenneco (NYSE:<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a>) reports&nbsp;revenue rose 7% on a constant currency basis in <a href=\"https://seekingalpha.com/pr/17070770-tenneco-reports-fourth-quarter-full-year-2017-results\" target=\"_blank\">Q4</a>, driven by higher volumes and incremental content on light vehicle, commercial truck and off-highway applications.</li><li>Clean Air division revenue increased 9.9% to $1.7B.</li><li>Ride Performance division revenue up 13.5% to $696M.</li><li>Original equipment light vehicle revenue advanced 7.2% to $1.79B.</li><li>Global aftermarket revenue was slightly higher Y/Y.<b><br></b></li><li>Adjusted EBIT slipped 10 bps to 7%.</li><li><b>Q1 Guidance</b>: Revenue: +3% (excluding currency impact).</li><li><b>FY2017 Guidance</b>: Revenue: +5%&nbsp;(excluding currency impact).; Tax rate: 23% to 25%; Capex: $380M to $410M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329831\" data-linked=\"More on Tenneco&#39;s Q4 beat\" data-tweet=\"$TEN - More on Tenneco&#39;s Q4 beat https://seekingalpha.com/news/3329831-on-tennecos-q4-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3329831-on-tennecos-q4-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329829\" data-ts=\"1518181622\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SRPT\" target=\"_blank\">SRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329829-sarepta-slips-7-premarket-on-golodirsen-study-halt\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sarepta slips 7% premarket on golodirsen study halt</a></h4><ul><li>Sarepta Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SRPT' title='Sarepta Therapeutics, Inc.'>SRPT</a>) is down&nbsp;<font color='red'>7%</font>&nbsp;premarket in reaction to the <a href=\"http://www.epvantage.com/Universal/View.aspx?type=Story&amp;id=764496&amp;isEPVantage=yes\" target=\"_blank\">news</a> that it has temporarily suspended dosing in a late-stage study of DMD candidate golodirsen.</li><li>The study, <a href=\"https://clinicaltrials.gov/ct2/show/NCT02500381?spons=sarepta+therapeutics&amp;rank=4\" target=\"_blank\">ESSENCE</a>, is evaluating exon 45-skipping SRP-4045 (golodirsen) and exon 53-skipping SRP-4053.</li><li>Apparently, one patient experienced a painful side effect called <a href=\"https://www.webmd.com/a-to-z-guides/rhabdomyolysis-symptoms-causes-treatments#1\" target=\"_blank\">rhabdomyolysis</a>, a condition where skeletal muscle breaks down rapidly. The dead cells are released into the bloodstream where they can cause serious problems.</li><li>EP Vantage reports that the safety data from ESSENCE has been reviewed by an independent monitoring committee which concluded that dosing could continue for all participants.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329829\" data-linked=\"Sarepta slips 7% premarket on golodirsen study halt\" data-tweet=\"$SRPT - Sarepta slips 7% premarket on golodirsen study halt https://seekingalpha.com/news/3329829-sarepta-slips-7-premarket-on-golodirsen-study-halt?source=tweet\" data-url=\"https://seekingalpha.com/news/3329829-sarepta-slips-7-premarket-on-golodirsen-study-halt\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329819\" data-ts=\"1518180864\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMPV\" target=\"_blank\">IMPV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329819-imperva-reports-q4-eps-beat-downside-revenue-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Imperva reports Q4 EPS beat, downside revenue guidance</a></h4><ul><li>                   Imperva (NASDAQ:<a href='https://seekingalpha.com/symbol/IMPV' title='Imperva, Inc.'>IMPV</a>) reports Q4 results that beat EPS estimates and met on revenue. Q1 and FY18 guidance feature EPS estimates above consensus but downside revenue. </li><li>           Q1 guidance (from <a href=\"https://seekingalpha.com/article/4144897-imperva-impv-q4-2017-results-earnings-call-transcript?part=single\" target=\"_blank\">earnings call</a>): Revenue, $82.5M to $84.5M (consensus: $85.39M); non-GAAP gross margin, 81%; operating profit, $7.5M to $8.5M; EPS, $0.17 to $0.20 (consensus: $0.13). &nbsp; </li><li> FY18 guidance: Revenue, $368M to $374M (consensus: $377.07M); non-GAAP gross margin, 81%; operating profit, $57M to $59M; EPS, $1.45 to $1.51 (consensus: $1.02); capital expenditures, $10M to $12M. </li><li>           Note that guidance is provided using the new Accounting Standard 606. &nbsp; </li><li> Analyst action: Piper Jaffray <a href=\"https://www.streetinsider.com/Analyst+Comments/Piper+Jaffray+Upgrades+Imperva+%28IMPV%29+to+Overweight/13787191.html\" target=\"_blank\">upgrades</a> Imperva (<a href='https://seekingalpha.com/symbol/IMPV' title='Imperva, Inc.'>IMPV</a>) to Overweight from Neutral and raises the price target by $10 to $52, a 24% upside to yesterday&rsquo;s close. </li><li> Analyst Andrew Nowinski says the FY18 guidance is too conservative and management has a strong history of exceeding expectations.&nbsp; </li><li>         Imperva shares are&nbsp;<font color='green'>up 2.7%&nbsp;</font>premarket.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3329569-imperva-beats-0_13-revenue-line\" target=\"_blank\">Imperva beats by $0.13,  revenue in-line</a> (Feb. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329819\" data-linked=\"Imperva reports Q4 EPS beat, downside revenue guidance\" data-tweet=\"$IMPV - Imperva reports Q4 EPS beat, downside revenue guidance https://seekingalpha.com/news/3329819-imperva-reports-q4-eps-beat-downside-revenue-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3329819-imperva-reports-q4-eps-beat-downside-revenue-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329814\" data-ts=\"1518179802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CCJ\" target=\"_blank\">CCJ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329814-cameco-beats-0_11-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cameco beats by $0.11, beats on revenue</a></h4><ul><li>Cameco (NYSE:<a href='https://seekingalpha.com/symbol/CCJ' title='Cameco Corporation'>CCJ</a>): Q4 EPS of $0.46 <font color='green'>beats by $0.11</font>.</li><li>Revenue of $809M (-8.8% Y/Y) <font color='green'>beats by $28.09M</font>.</li><li>Shares <font color='green'>+1.34%</font> PM.</li><li><a href='https://seekingalpha.com/pr/17070715-cameco-reports-fourth-quarter-2017-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3329814\" data-linked=\"Cameco beats by $0.11, beats on revenue\" data-tweet=\"$CCJ - Cameco beats by $0.11, beats on revenue https://seekingalpha.com/news/3329814-cameco-beats-0_11-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3329814-cameco-beats-0_11-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:36 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329812\" data-ts=\"1518179774\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329812-tandem-sees-up-to-40m-in-q4-sales-up-to-140m-this-year-investors-unmoved-shares-down-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tandem sees up to $40M in Q4 sales, up to $140M this year; investors unmoved, shares down 20% premarket</a></h4><ul><li>Tandem Diabetes Care (NASDAQ:<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>) slumps&nbsp;<font color='red'>20%</font>&nbsp;permarket after the company announced <a href=\"https://seekingalpha.com/pr/17042808-tandem-diabetes-care-announces-preliminary-2017-results-provides-2018-guidance\" target=\"_blank\">preliminary Q4 and 2017 results</a> and its outlook for this year.</li><li>Q4 2017: Sales should be $39M - 40M. Pump shipments: ~7,000 (+58%).</li><li>2017: Sales should be $106M - 107M. Pump shipments: ~17,100 (+1.0%).</li><li>Consensus sales views for Q4 and 2017 are $38M and $100.7M, respectively.</li><li><strong>2018 guidance</strong>: Sales: $132M - 140M. Consensus view is $132.5M.</li><li>Final results will be released on March 1 after the close.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329812\" data-linked=\"Tandem sees up to $40M in Q4 sales, up to $140M this year; investors unmoved, shares down 20% premarket\" data-tweet=\"$TNDM - Tandem sees up to $40M in Q4 sales, up to $140M this year; investors unmoved, shares down 20% premarket https://seekingalpha.com/news/3329812-tandem-sees-up-to-40m-in-q4-sales-up-to-140m-this-year-investors-unmoved-shares-down-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3329812-tandem-sees-up-to-40m-in-q4-sales-up-to-140m-this-year-investors-unmoved-shares-down-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329809\" data-ts=\"1518179474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DDD\" target=\"_blank\">DDD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329809-3d-systemsminus-1_7-on-analyst-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">3D Systems -1.7% on analyst downgrade</a></h4><ul><li>           JPMorgan <a href=\"https://www.streetinsider.com/Analyst+Comments/JPMorgan+Downgrades+3D+Systems+%28DDD%29+to+Underweight/13787240.html\" target=\"_blank\">downgrades</a> 3D Systems (NYSE:<a href='https://seekingalpha.com/symbol/DDD' title='3D Systems Corp.'>DDD</a>) from Neutral to Underweight with an $11 price target, a 12% upgrade on yesterday&rsquo;s closing price. </li><li> Analyst Paul Coster cites valuation and doesn&rsquo;t believe 3D is a good short candidate. </li><li> 3D Systems shares are&nbsp;<font color='red'>down 1.7%</font>&nbsp;premarket. &nbsp;&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3329809\" data-linked=\"3D Systems -1.7% on analyst downgrade\" data-tweet=\"$DDD - 3D Systems -1.7% on analyst downgrade https://seekingalpha.com/news/3329809-3d-systemsminus-1_7-on-analyst-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3329809-3d-systemsminus-1_7-on-analyst-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329803\" data-ts=\"1518178847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FEYE\" target=\"_blank\">FEYE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329803-susquehanna-upgrades-fireeye\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Susquehanna upgrades FireEye</a></h4><ul><li>        Susquehanna upgrades FireEye (NASDAQ:<a href='https://seekingalpha.com/symbol/FEYE' title='FireEye, Inc.'>FEYE</a>) from Neutral to Positive following yesterday&rsquo;s earnings report.</li><li>               Susquehanna analyst Anne Meisner <a href=\"https://www.reuters.com/article/us-fireeye-results/fireeye-reports-first-ever-adjusted-quarterly-profit-shares-jump-idUSKBN1FS388https://www.reuters.com/article/us-fireeye-results/fireeye-reports-first-ever-adjusted-quarterly-profit-shares-jump-idUSKBN1FS388\" target=\"_blank\">says</a> the deferred revenue mix hints at continued contraction in contract lengths as the mix shifts towards SaaS and other subscription products. &nbsp;&nbsp;</li><li>               FireEye shares are&nbsp;<font color='green'>up 13.9%</font>&nbsp;premarket.&nbsp;&nbsp;&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329650-fireeye-plus-12_8-percent-q4-beats-upside-guidance\" target=\"_blank\">FireEye +12.8% after Q4 beats, upside guidance</a> (Feb. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3329803\" data-linked=\"Susquehanna upgrades FireEye\" data-tweet=\"$FEYE - Susquehanna upgrades FireEye https://seekingalpha.com/news/3329803-susquehanna-upgrades-fireeye?source=tweet\" data-url=\"https://seekingalpha.com/news/3329803-susquehanna-upgrades-fireeye\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329802\" data-ts=\"1518178747\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FDX\" target=\"_blank\">FDX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329802-amazon-shadow-sends-fedex-and-ups-lower\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Amazon shadow sends FedEx and UPS lower</a></h4><ul> <li>FedEx (NYSE:<a href='https://seekingalpha.com/symbol/FDX' title='FedEx Corporation'>FDX</a>) and UPS (NYSE:<a href='https://seekingalpha.com/symbol/UPS' title='United Parcel Service, Inc.'>UPS</a>) are lower in premarket trading after a brighter spotlight is turned on Amazon's (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) plan to run a delivery service.</li> <li>The Wall Street Journal <a href=\"https://www.wsj.com/articles/amazon-to-launch-delivery-service-that-would-vie-with-fedex-ups-1518175920\" target=\"_blank\">reports</a> that Amazon is expected to roll out the service in the next couple of weeks with third-party merchants that sell good off its site.</li> <li>A launch to other select U.S. cities is anticipated to happen later this year.</li> <li>FedEx is <font color='red'>down 4.31%</font> premarket, while UPS is <font color='red'>4.83% lower</font>. Amazon is <font color='green'>up 0.32%</font> to $1,354.80.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329802\" data-linked=\"Amazon shadow sends FedEx and UPS lower\" data-tweet=\"$FDX $FDX $UPS - Amazon shadow sends FedEx and UPS lower https://seekingalpha.com/news/3329802-amazon-shadow-sends-fedex-and-ups-lower?source=tweet\" data-url=\"https://seekingalpha.com/news/3329802-amazon-shadow-sends-fedex-and-ups-lower\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>109&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329800\" data-ts=\"1518178474\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BPTH\" target=\"_blank\">BPTH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329800-bio-path-executes-1-10-reverse-split-of-common-stock\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bio-Path executes 1:10 reverse split of common stock</a></h4><ul><li>Aimed at regaining compliance with Nasdaq's listing requirement of a $1 minimum bid price, Bio-Path Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/BPTH' title='Bio-Path Holdings, Inc.'>BPTH</a>) executed a <a href=\"https://seekingalpha.com/pr/17070688-bio-path-holdings-announces-1minus-10-reverse-stock-split\" target=\"_blank\">1:10 reverse split</a> of its common stock yesterday after the close (5:00 pm ET). Post-split trading commences today at the open.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329800\" data-linked=\"Bio-Path executes 1:10 reverse split of common stock\" data-tweet=\"$BPTH - Bio-Path executes 1:10 reverse split of common stock https://seekingalpha.com/news/3329800-bio-path-executes-1-10-reverse-split-of-common-stock?source=tweet\" data-url=\"https://seekingalpha.com/news/3329800-bio-path-executes-1-10-reverse-split-of-common-stock\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:14 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329798\" data-ts=\"1518178271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEMI\" target=\"_blank\">CEMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329798-chembio-prices-stock-offering-6_75\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chembio prices stock offering at $6.75</a></h4><ul><li>Chembio Diagnostics (NASDAQ:<a href='https://seekingalpha.com/symbol/CEMI' title='Chembio Diagnostics, Inc.'>CEMI</a>) <a href=\"https://seekingalpha.com/pr/17070692-chembio-diagnostics-announces-pricing-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 1,783,760 shares of common stock at $6.75 per share. Closing date is February 13.</li><li>Yesterday's close was $7.75.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329798\" data-linked=\"Chembio prices stock offering at $6.75\" data-tweet=\"$CEMI - Chembio prices stock offering at $6.75 https://seekingalpha.com/news/3329798-chembio-prices-stock-offering-6_75?source=tweet\" data-url=\"https://seekingalpha.com/news/3329798-chembio-prices-stock-offering-6_75\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329789\" data-ts=\"1518177475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EXPE\" target=\"_blank\">EXPE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329789-marketing-expenses-sting-expedia\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Marketing expenses sting Expedia</a></h4><ul> <li>Expedia (NASDAQ:<a href='https://seekingalpha.com/symbol/EXPE' title='Expedia, Inc.'>EXPE</a>) is sharply lower after <a href=\"https://seekingalpha.com/news/3329574-expedia-misses-0_31-misses-revenue\" target=\"_blank\">Q4</a> profit missed consensus estimates due chiefly to higher marketing expenses.</li> <li>Investors may also be latching on the Expedia's high level of spending planned for 2018 in the hope of stoking EBITDA growth in the second half of the year.</li> <li>On Wall Street, Benchmark lowered Expedia to a Hold rating from Buy after taking in the numbers.</li> <li>Shares of Expedia are <font color='red'>down 17.58%</font> in premarket trading to $101.40.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3329574-expedia-misses-0_31-misses-revenue\" target=\"_blank\">Expedia misses by $0.31, misses on revenue</a> (Feb. 8)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3329789\" data-linked=\"Marketing expenses sting Expedia\" data-tweet=\"$EXPE - Marketing expenses sting Expedia https://seekingalpha.com/news/3329789-marketing-expenses-sting-expedia?source=tweet\" data-url=\"https://seekingalpha.com/news/3329789-marketing-expenses-sting-expedia\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329775\" data-ts=\"1518176005\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAGE\" target=\"_blank\">SAGE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329775-sage-price-stock-offering-164\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sage price stock offering at $164</a></h4><ul><li>Sage Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/SAGE' title='Sage Therapeutics'>SAGE</a>) <a href=\"https://seekingalpha.com/pr/17070601-sage-therapeutics-prices-public-offering-common-stock\" target=\"_blank\">prices </a>its public offering of 3,506,098 shares of common stock at $164 per share. Underwriters over-allotment is an additional 525,914 shares. Closing date is February 13.</li><li>Yesterday's close was $166.05.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329775\" data-linked=\"Sage price stock offering at $164\" data-tweet=\"$SAGE - Sage price stock offering at $164 https://seekingalpha.com/news/3329775-sage-price-stock-offering-164?source=tweet\" data-url=\"https://seekingalpha.com/news/3329775-sage-price-stock-offering-164\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3329771\" data-ts=\"1518175876\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CEMI\" target=\"_blank\">CEMI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3329771-chembio-readies-stock-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Chembio readies stock offering</a></h4><ul><li>Chembio (NASDAQ:<a href='https://seekingalpha.com/symbol/CEMI' title='Chembio Diagnostics, Inc.'>CEMI</a>) <a href=\"https://seekingalpha.com/pr/17070513-chembio-diagnostics-announces-proposed-public-offering-common-stock\" target=\"_blank\">commences </a>a public offering of common stock. Price, volume and terms have yet to be announced.</li></ul><div class=\"tiny-share-widget\" data-id=\"3329771\" data-linked=\"Chembio readies stock offering\" data-tweet=\"$CEMI - Chembio readies stock offering https://seekingalpha.com/news/3329771-chembio-readies-stock-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3329771-chembio-readies-stock-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:31 AM </div></div></li>","count":75,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}